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ABSTRACT 
MOLECULAR CLONING AND ANALYSIS OF THE PROMOTER FOR RAT 
HEPATIC NEUTRAL CHOLESTEROL ESTER HYDROLASE 
By Ramesh Natarajan, Ph.D. 
A dissertation submitted in partial fulfil lment of the requirements for the degree of 
Doctor of Philosophy at V irginia Commonwealth University. 
V irginia Commonwealth University, 1 997. 
Major Director: W. McLean Grogan, Professor, Department of B iochemistry and 
Molecular B iophysics 
Neutral cholesterol ester hydrolase (CEH) is a key enzyme in regulating hepatic 
free cholesterol. Using the CEH specific eDNA sequence in the 5' -untranslated region as 
a primer, 1 . 3 kb of sequence upstream of the ATG init iation codon was ampl ified and 
cloned. Primer extension analysis with total RNA from rat primary hepatocytes 
identified a transcription init iation site, 60 bases upstream from the init iation codon. No 
typical TAT A-box sequences were found upstream from the transcription start site. 
However, a consensus GC-box, which can bind the positive transcription factor SP I, was 
found 35 bases upstream from the transcription start site. In addit ion the promoter also 
contained several hormone responsive half elements, sterol response elements, ubiquitous 
transcription factor binding sites and liver specific elements. 
X 
To determine the promoter activity of the rat CEH gene, the 1 .3 kb of 5' -flanking 
region was fused to a luciferase reporter gene. Smaller 5' -deletion constructs were 
obtained by generation of unidirectional nested deletion breakpoints in the fu ll- length 
construct with Exonuclease III. Basal promoter activity, as well as transcriptional 
regulation by hormones, signal transduction pathways and agents perturbing cholesterol 
metabolism were studied in human hepatoblastoma HepG2 cells and cultured primary rat 
hepatocytes by transient transfection assays of the promoter activity of the deletion 
constructs. Functional glucocorticoid response elements, phorbol ester responsive 
sequences and sterol responsive sequences were mapped with both the culture systems. 
Results indicate that the first 599 base pairs upstream of the initiation codon and the 
region between nucleotides - 1 3 1 7 and - 1 1 90 regulate the effects of various physiological 
stimuli .  The effects of various stimuli used in this study were similar in the two cell 
lines. The rat CEH gene appears to be finely regulated by distinct signals converging to 
consensus promoter regulatory sequences. 
INTRODUCTION 
Cholesterol ester hydrolases (CEH) are a family of ubiquitous enzymes that are 
found in many organisms. In mammals they occur in many tissues and are associated 
w ith different functions, depending on location. They have been found in l iver (Deykin 
and Goodman , 1 962) , pancreas (Calame et al, 1 975),  adrenals (Trzeciak and Boyd , 
1 974 ) ,  testis (Durham and Grogan, 1 982), intestine (Gallo et al, 1 980), mammary glands 
(Martinez and Botham, 1 990) , placenta (Chin and Morin , 1 97 1  ), brain (Eto and Suzuki, 
1 972) ,  adipose tissue (Pittman et al, 1 975),  macrophages (Small et al, 1 989),  artery 
(Hajjar et al, 1 983) and corpus luteum (Cook et al, 1 983) ,  where they catalyze the release 
of free cholesterol and fatty acids from cholesteryl esters, an intracellular storage form o f  
cholesterol. Mult ip le forms o f  CEH have been reported i n  testis (Durham and Grogan , 
1 984 ) ,  brain (Eto and Suzuki, 1 972), adrenals (Pittman and Steinberg, 1 977) and l iver 
(Deykin and Goodman, 1 962; Nilsson, 1 976). They have been identified in different sub­
cellular organelles including cytosol (Deykin and Goodman, 1 962), lysosomes (Lundberg 
et al, 1 990), endoplasmic reticulum (Gandarias et al, 1 987), mitochondria (Deykin and 
Goodman, 1 962) and nuclei (Deykin and Goodman, 1 962). Whi le the pancreatic and 
intestinal CEH' s  have a digestive role, the CEH in adipose tissues and steroidogenic 
organs provide substrate for steroidogenesis. The lysosomal CEH on the other hand 
hydrolyses cholesteryl and glyceryl esters during lipoprotein degradation. Although rat 
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l iver contains both lysosomal and microsomal CEH activities, the major hydrolytic 
activity is associated with a unique cytosolic cholesterol ester hydrolase that is 
appropriately located, rationally regulated and is capable of mobilizing free cholesterol 
from cholesteryl ester stores (Natarajan et al, l 996a) . However, because most of the 
research to date has focussed on the bi le salt-stimulated cholesterol esterase found 
initially in the pancreas and the hormone sensitive l ipase I cholesterol esterase found in 
steroidogenic t issues, I will  briefly review these enzymes prior to discussing the 
properties of the hepatic cytosolic CEH. 
Bile salt-stimulated cholesterol esterase 
The bile salt stimulated cholesterol esterase has been purified fro m  many different 
sources including rat and human pancreatic juice (Gallo, 1 98 1 ;  Lombardo et al, 1 978) ,  
pancreas from different species (Wang, 1 988;  Jacobson et al, 1 990; Rudd et al, 1 987), rat 
l iver (Camul l i  et al, 1 989) and human milk (Rudd and Brockman, 1 984; Wang and 
Hartsuck, 1 993) . This enzyme has a broad substrate specificity. In addition to the 
hydrolysis of cholesteryl esters, the enzyme is capable of hydrolyzing mono-, di-, and 
triacylglycerol, phospholipids, and esters of fat-soluble vitamins. Enzyme activity 
against these substrates can be activated several fo ld by bile salt, with the trihydroxylated 
bile salts being more potent than their dihydroxylated counterparts (Hernell and 
Olivecrona, 1 974; Blackberg and Hernell, 1 993) . This enzyme can also hydrolyze 
lysophospholipid (Han et al, 1 987). However, this activity is bile salt-independent. The 
bile salt-stimulated cholesterol esterase has also been demonstrated to have l ipoamidase 
act ivity (Hui et al, 1 993). Han et al were the first to report the primary sequence of this 
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protein, based on isolation and cloning o f  a 2 kb full-length transcript from rat pancreas. 
Hui et al used an independent approach, based on immunoreactivity, partial protein 
sequencing , and cloning of the eDNA to confirm identity between the pancreatic 
lysophopholipase and cholesterol esterase. The sequence o f  bile salt-stimulated lipase 
found in milk was also shown to be identical to the pancreatic cholesterol esterase (Hui 
and Kissel, 1 990; N ilsson et al, 1 990) , thereby establishing the identity between these 
proteins. The cholesterol esterase sequence displays a high degree of homology with 
other serine esterases, such as acetylcholinesterase and cholinesterase. These proteins 
contain the catalytic triad serine-histidine-acidic residue at simjlar locations o f  the 
protein. 
The complete sequence of the bi le salt-stimulated cholesterol esterase gene has 
been determined in the rat (Fontaine et al, 1 99 1  ), and partial sequences with intron-exon 
junctions have been reported for both the human and the mouse cholesterol esterase gene 
(Lidmer et al, 1 995 ;  Lidberg et al, 1 992). Both the rat and the mouse cholesterol esterase 
genes are single copy genes in their respective genomes , spanning approximately 7 kb. 
The human gene is approximately 9 kb in length, and is present in the human genome 
along with a cholesterol esterase- like gene. The 5' flanking region of the cholesterol 
esterase gene shares several homologous domains with that of the pancreatic lipase gene 
(Mickel et al, 1 989).  There are 5 distinct sequences each spanning at least I 0 residues, 
that are similar between the cholesterol esterase and pancreatic lipase genes. S ince the 
pancreatic l ipase has a key role in dietary lipid absorption, it has been suggested that the 
cholesterol esterase synthesized by the pancreas may be involved in a s imilar process. 
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The 5' flanking region also contains consensus sequences for pancreas specific enhancer 
elements (Fontaine et al, 199 1 ;  Lidberg et al, 1 992), a tissue-specific mammary g land 
factor recognition sequence (Lidberg et al, 1 992) and an I I  bp conserved sequence 
present in a number of milk protein genes (Lidberg et al, 1 992) such as lactalbumin and 
casein. This consensus sequence may be responsible for cholesterol esterase gene 
expression in lactating mammary g lands. 
In addition to transcriptional regulat ion, cholesterol esterase biosynthesis is also 
regulated post-transcript ional ly in response to gastric hormones like cholecystokinin, 
secretin and bombesin. The hormone-induced cholesterol esterase biosynthesis is not 
dependent on de novo RNA synthesis and does not alter the level of cholesterol esterase 
mRNA (Huang and Hui, 1 99 1  ) .  Instead hormonal treatment increases translational 
efficiency of the cholesterol esterase mRNA. The hormone-induced cholesterol esterase 
biosynthesis is mediated via calcium mobilization and protein kinase C-dependent 
mechanisms (Brodt-Eppley and Hui,  1 995). 
Disruption of the cho lesterol esterase gene m knockout experiments 
abolished cholesterol esterase activity in the intestinal tract. However, while cholesterol 
absorption efficiency was unaffected, the absorption of cho lesteryl esters was 
dramatical ly decreased in the cho lesterol esterase knockout mice (Howles et al, 1 996), 
suggesting that cholesterol esterase is not involved in the cholesterol absorption process 
but is only important for the absorption of substrates with carboxy lester bonds. 
Hormone sensitive lipase 
Hormone sensitive l ipase (HSL) is another enzyme with high cho lesterol esterase 
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activity.  Although this protein was originally isolated based on its abi l ity to hydrolyze 
triglyceride, subsequent characterizat ion of the protein revealed its abi l ity to hydrolyze 
cholesteryl esters w ith equal e fficiency. The HSL is most abundant in adipose tissue, 
heart, skeletal muscle and in steroidogenic tissues such as the adrenals ,  ovary and testes. 
In contrast to the bile salt-stimulated cholesterol esterase, which requires direct 
interaction of the bi le salt with the enzyme for activation, bi le salt is not a required 
cofactor for HSL. 
The primary structure of HSL was deduced by cloning and sequencing of the 
eDNA, from both rat and human adipose tissue (Holm et al, 1 988; Lombardo et al, 
1993). The HSL contains within its sequence the GXSXG motif, a characteristic of other 
serine esterases and lipases. However, the histidine and acidic amino-acid residue in the 
catalyt ic triad have yet to be identified. 
As the name impl ies, the HSL hydrolytic activity is stimulated by l ipolyt ic 
hormones such as catecholamines. The mechanism o f  action is through cAMP-dependent 
protein kinase-mediated phosphorylation of a serine residue (Holm et al, 1 988). In 
contrast, the inactivation of  the HSL by anti-lipolytic hormones, such as insu lin, is 
indirect through lowering of the cAMP level by a cAMP phosphodiesterase. 
The HSL gene spans approximately I 0 kb and contains 9 exons (Lang in et al, 
1 993). The intron-exon organization of the HSL gene resembles that of the bile salt-
stimulated cholesterol esterase, with each exon encoding a key functional domain of the 
protein. The 5' flanking region of the mouse HSL gene has adipose tissue speci fic 
elements (Rice et al, 1 990) and an element responsible for protamine I gene expression 
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m the testes (Tamura et al, 1992). The presence o f  the consensus sequences in the 
regulatory region of the HSL gene is consistent with its expression m these t issues. 
Consensus sequences for Ets- 1 and Pu. I are also present, suggesting that these may 
represent cis-acting elements responsible for monocyte/macrophage expression o f  this 
gene ( Kiemsz et al, 1 990). In addition, a preadipocyte repressor element (Swick and 
Lane, 1992) and sterol regulatory element- ! sequences (Goldstein and B rown, 1 990) are 
also present. 
Although HSL activity I immunoreactivity was originally found in the adipose 
tissue, it has been shown to be present in the heart, skeletal muscle, adrenals, ovaries, 
p lacenta and in some macrophage cell lines (Kraemer et al, 1 993). It has been proposed 
that the HSL in adipose tissue, skeletal muscle and heart serves as a triacylglycerol lipase 
in supply ing fatty acids to these tissues. On the other hand, its role in ovaries and 
adrenals may be related to its cholesteryl ester hydrolytic activity and it possibly 
mobilizes cholesteryl ester stores for steroid biosynthesis. HSL is also found in the testes 
where it is expressed in a stage-dependent manner, coinciding w ith the onset of  
spermatogenesis. Testicular expression of  the gene was localized to  Sertol i  cells instead 
o f  the Leydig cells (Holst et al, 1994), suggesting that the role o f  this protein in the testis 
is most likely related to mobilization of lipid droplets in Sertoli cells rather than for 
steroid biosynthesis in Leydig cells. As mentioned be fore, the HSL is also found in 
several mouse macrophage cell l ines. The functional signi ficance for macrophage 
expression o f  the HSL is speculated to be the hydrolysis o f  cholesteryl esters liberating 
free cholesterol for efflux from the cells (Khoo et al, 1 98 1; Small et al, 1 989). Based on 
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these observations, the importance of this enzyme tn dictating macrophage foam cell 
formation and in athergenesis has been postulated. 
Cytosolic Cholesterol Ester Hydrolase : Isolation and cloning 
The cytosolic CEH represents the major regulated cholesterol ester hydrolytic 
activity in rat liver. Conventional protein purification procedures have been used in this 
laboratory to purify this hepatic CEH from rat livers (Ghosh and Grogan, 1 99 1). The 
enzyme was purified 1 2,600 - fo ld by ammonium sulfate precipitation, cation exchange 
chromatography and gel permeat ion high pressure l iquid chromatography w ith an overall 
yield of 20%. The identity of this enzyme has been a controversy for over a decade. 
Gallo et al first suggested that hepatic CEH is different from the pancreatic CEH, by 
showing that antibodies to pancreatic CEH did not cross react with hepatic CEH. But 
Harrison et al reported that the anti-pancreatic CEH antibodies (supplied by Gallo) could 
inhibit 72% of hepatic CEH activity and therefore suggested identity between these 
enzymes. Camul l i  et al isolated a liver protein using anti-pancreatic CEH antibodies on 
an antibody affinity column.  However this protein had properties different from the 
hepatic CEH. Kissel et al then cloned the eDNA for rat pancreatic CEH and 
demonstrated the presence of corresponding RNA in rat liver. However the CEH purified 
by Ghosh and Grogan ( 199 1 )  differs from the pancreatic CEH in several ways. This 
hepatic CEH has orders of magnitude greater total activity than pancreatic CEH, is 
protein kinase A activated, is bile salt independent and has no cross reactivity w ith ant i-
pancreatic CEH antibodies. Also a specific neutralizing antibody to hepatic CEH 
generated in this laboratory cross reacted only weakly w ith pancreatic CEH on Western 
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blots (Ghosh and Grogan , 1992). More recently a 1 923 bp eDNA for rat hepatic CEH 
was cloned by screening a rat l iver lambda gt I I  eDNA l ibrary with an end-labelled 
synthetic o ligonucleotide derived from the conserved active site sequence of rat and 
human pancreatic cholesterol esterase and human milk bile salt stimulated l ipase (Ghosh 
et al, 1995). This eDNA hybridized to a single strong 2.3 kb band on Northern blots o f  
rat l iver mRNA and included an open reading frame coding for 565 amino acids, 
corresponding to a protein of molecular weight 62 143 (unglycosylated), consistent with 
the 66 kDa mobility of rat liver CEH on SDS-PAGE. The eDNA sequence for hepatic 
CEH has only 44% homo logy with pancreatic CEH, whereas the predicted amino acid 
sequence has only 3 1 % identity. The identity of the eDNA obtained with the puri fied 
CEH was demonstrated by immunoreactivity of ant ibodies to hepatic CEH with the 
fusion protein produced by the recombinant phage and w ith protein expressed in a 
prokaryotic expression system, and also by production o f  h igh levels o f  hepatic CEH 
activity and a 66 kDa immunoreactive protein in COS cells trans fected with an 
expression vector containing the fu ll- length eDNA (Ghosh et al, 1995). 
Characterization of hepatic cytosolic CEH 
The purified hepatic CEH exhibited activity over the pH range 5.0 - 9.0 with 
optimal activity at pH 7.0 to 7.5 (Ghosh and Grogan, 199 1 ). The purified enzyme eluted 
as a single peak from a FPLC chromatofocussing column corresponding to a pi value o f  
5.5 (Ghosh and Grogan , 1 99 1  ) .  As mentioned earlier, hepatic CEH i s  activated by 
cAMP-dependent protein kinase (PKA) and also by ci+- phospholipid dependent protein 
kinase (PKC).  Thus, CEH is regulated by reversible phosphorylation, with the 
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phosphorylated form being the more active form (Ghosh and Grogan, 1 989). Whereas 
the cytosolic enzyme is bile salt independent, the purified enzyme is activated by 
increasing taurocholate concentrations up to I mM. The activation remained more or less 
constant up to I 0 mM and then declined with further increases in concentration (Ghosh 
and Grogan, 1 99 1  ). Purified hepatic CEH is strongly inhibited by 20 - 40 mM 
taurocholate in marked contrast to the pancreatic CEH which is known to be activated by 
bile salts in this concentration range. While the purified CEH requires a minimal level of 
taurocholate (0.25 mM) to prevent aggregation of the enzyme to an inactive state, bile 
salts can also modify the physical state of the substrate. The purified enzyme hydrolyzes 
oleoyl esters of both cholesterol and glycerol, although the activity was consistently 
higher with cholesteryl o leate than w ith triolein at all taurocholate concentrations 
(Natarajan, et al, 1 996a). With cholesteryl oleate as a substrate, enzyme activity rapidly 
increased between 2.5 - 6 .5 f..iM and gradually increased thereafter with further increases 
up to 300 f..iM. Thus, typical of enzymes with insoluble substrates, this CEH did not 
saturate with substrate within the range of feasible substrate concentrations. The activity 
of purified CEH is also independent of divalent metal ions like Zn+2, Cu+2 and Cd+2 . 
However these cations were mildly inhibitory at one or more concentrations from I -
1 000 f..iM (Natarajan et al, 1 996a). 
CEH belongs to the family of serine esterases which are characterized by the 
presence of a conserved catalytic triad (serine, histidine and an acidic residue). Simi lar to 
other cholesterol esterases, purified CEH was inhibited by phenylmethylsulfonylfluoride 
(PMSF), with 50% inhibition at 0. 1 mM PMSF (Natarajan et al, 1 996a). This is 
1 0  
consistent with the identification o f  the consensus serine esterase active site. The 
sulfhydryl specific agent mercury benzoate, inhibited the enzyme activity 30% at 3 mM 
(Natarajan et al, 1 996a). Inasmuch as iodoacetamide and N-ethylmaleimide affected a 
modest activation, inhibition by Hg +2 probably reflects a general effect of divalent 
cations, rather than an interaction with an essential sulfhydryl group. Since CEH 
catalyzes the hydrolysis of uncharged esters and is inh ibited by Cu+2 and Hg+2, but not by 
iodoacetamide, it has the properties of a class A esterase, as described by Aldridge, 1 953 .  
In addition to  its abi l ity to  hydrolyze physiologically relevant substrates like cholesteryl 
oleate and triolein, this cytosolic CEH can also hydrolyze paranitrophenyl (PNP)- esters 
of fatty acids. While esterases like l ipoprotein lipase and pancreatic CEH can efficiently 
hydrolyze the water soluble substrate PNP-acetate, hepatic CEH demonstrated the lowest 
activity towards this substrate. Activity increased with chain length, peaked with the 
more lipophil ic PNP-caprylate and then declined gradually with increasing chain length > 
C8 (Natarajan et al, 1 996a) . However hydrolytic act ivity was consistently higher with the 
more lipophil ic esters than with PNP-acetate. 
Serine esterases such as lipoprotein lipases and hepatic lipase have highly variable 
trypsin- labile loop structures formed by disulfide bridges, which confer substrate binding 
specificity. Trypsin cleavage at a specific site in this loop abolishes lipoprotein lipase 
activity with triolein but not with more hydrophil ic tributyrin.  Mild trypsin digestion of 
the purified CEH results in progressive and selective loss of activity with cholesteryl 
oleate and triolein, but not with more hydrophi l ic PNP-caprylate. Analysis of CEH by 
SDS-PAGE after 24 hrs. of trypsin digestion revealed only a single band at 66 kDa, 
I I  
indistinguishable from the mobility of the unmodified protein (Natarajan et al, 1 996a). 
By analogy with l ipoprotein l ipase, this is consistent with the cleavage of a single peptide 
bond within a loop domain which confers substrate specificity on CEH. Analysis of 
secondary structure for CEH by the GCG program (PEPTIDESTRUCTURE),  using 
algorithms for hydrophilicity (Kyte-Doolittle), surface probabil ity  (Emini) ,  chain 
flexibil ity ( Karplus-Schulz) and secondary structure (Chou-Fasman and Garnier­
Osguthorpe-Robson) ,  predicts such a loop between Cys87 and Cys116, containing a highly 
exposed trypsin cleavage site at Arg104. This site has a high hydrophil icity index (2.4), a 
high surface probabil ity (5 .8)  and a predicted turn. 
The hepatic cytosolic CEH is also developmentally regulated in the rat. In male 
rats, age-related differences in mRNA, protein mass and catalytic activity suggest 
transcriptional regulation and indicate an important role for CEH in cholesterol 
homeostasis in the developing rat (Natarajan et al, 1 996). On the other hand, in female 
rats it appears that hepatic CEH is subject to gender-specific multivalent regulation by 
post-translational mechanisms (Natarajan et al, 1 997). 
Regulation of cholesterol homeostasis in the liver 
As mentioned before, CEH releases free cholesterol from cholesteryl esters. Free 
cholesterol is an important structural component of cellular membranes. It has profound 
effects on physical properties of membranes, as well as membrane associated activities 
including enzymes and receptors involved in cholesterol metabolism and homeostasis 
(Liscum and Underwood, 1 995). This free cholesterol is not evenly distributed among 
the various membrane classes. While plasma membranes are relatively rich in 
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cholesterol, the endoplasmic reticulum has much lower cholesterol concentrations. The 
mechanisms required to maintain this gradient are not well understood as yet. 
Hepatic free cholesterol pools play important roles in the regulation of receptor 
mediated uptake of cholesterol, in the de novo biosynthesis of cholesterol, in bile acid 
synthesis, in the esterification of free cholesterol and in the hydrolysis of stored 
cholesteryl esters. Intracellu lar levels of free cholesterol are maintained relat ively  
constant over a broad range of  metabolic states and cholesterol fluxes through the l iver 
(Gould, 1 977;  Klauda et al, 1 978; Erickson et al, 1 980). While de novo cholesterol 
biosynthesis and uptake of dietary cholesterol as lipoproteins are the two input pathways 
for cholesterol, conversion of hepatic cholesterol to bile acids and bil iary secretion of 
cholesterol are the only significant output pathways (Fig. I). In response to cholesterol 
influx or efflux, sterol balance in the hepatocyte is maintained by altering the flux  of 
cholesterol through I) endogenous cholesterol biosynthesis regulated by 3-hydroxy-3-
methylglutaryl-coenzyme A synthase (HMGCoAS) and the rate limit ing enzyme 3-
hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCoAR), 2) lipoprotein uptake, 
synthesis and secretion which is part ly regulated by the low density l ipoprotein (LDL) 
receptor, 3) conversion of cholesterol to bile acids which is regulated by sterol-27-
hydroxylase and the rate limiting enzyme cholesterol-7a-hydroxylase (C7H) and 4) 
reversible conversion of excess cholesterol to cholesteryl esters by 
acylcoenzymeA:cholesterol acyltransferase (ACAT) and hydrolysis of stored cholesteryl 
esters to free cholesterol by CEH. 
Regulation of the LDL receptor and the other enzymes HMGCoAS, HMGCoAR, 
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Figure I .  Regulation of cholesterol homeostasis in the rat liver. This figure shows the 
input and output pathways involved in the regulation of cholesterol homeostasis in the rat 
l iver as described in the text. 
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C7H, stero l-27-hydroxylase and ACAT have been studied i n  considerable detail .  
HMGCoAS, HMGCoAR and the LDL receptor are actively regulated by transcriptional, 
translational and post-translational modes (Goldstein and Brown, 1 990). C7H is 
primarily regulated at the transcriptional level (Spady and Cuthbert, 1 992) . There is 
some controversy regarding the ident ity of ACAT and its regulatory mechanisms are as 
yet unclear. While a detailed explanation of the regulation of these enzymes is beyond 
the scope of this dissertation, it is useful to review their regulation at the transcriptional 
level .  
The promoters for the LDL receptor (Osborne et al, 1 988),  HMGCoAS (Smith et 
al, 1 988)  and HMGCoAR (Dawson et al, 1 988) have been identified and characterized. 
They are regulated through sterol regulatory elements (SRE- 1 )  in their promoters that 
behave as conditional positive or conditional negative regulators of transcription when 
bound by the sterol regulatory element binding protein (SREBP). The details of this 
process are described in the following section. The C7H promoter has also been 
identified and characterized (Jelinek and Russell, 1 990; Nishimoto et al, 1 99 1 ; Chiang et 
al, 1 992). No SRE ' s  have yet been found in the C7H promoter. However the gene is 
regulated by different physiological stimuli including bile acids, hormones and signal 
transducing agents (Crestani et al, 1 994; Chiang and Stroup, 1 994; Crestani et al, 1 995). 
While an ACAT eDNA has recently been identified, no information is available on its 
promoter (Chang et al, 1 993). 
Another common mode of regulation is the short-term regulation of HMGCoAR, 
C7H, ACAT and CEH by reversible phosphorylation. In contrast to HMGCoAR which 
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is inhibited by phosphorylation and activated by dephosphorylat ion, the activities of C7H 
and ACAT are increased by in vitro phosphorylation (Gavey et al, 1 983; Goodwin et al, 
1 982; Beg et al, 1 987). As mentioned before, CEH is also regulated by reversible 
phosphorylation and the phosphorylated form is the active form. Based on these 
observations there appears to be a coordinated control of the enzymes involved in 
regulation of cholesterol homeostasis in the l iver by reversible phosphorylation. Under 
conditions of increased phosphorylation in the cell, HMGCoAR would be inh ibited and 
the free cholesterol pools would be depleted due to increased activit ies of ACAT and 
C7H. CEH, which is more active in the phosphorylated state, would then be important in 
maintaining the free cholesterol level in the cell .  However, a mechanism by which 
cellular cholesterol levels might affect the phosphorylation status of the various enzymes 
has not been demonstrated. 
Unl ike free cholesterol, the levels of intracellular cholesteryl esters vary greatly 
with rates of influx and efflux of cholesterol from the liver. They serve as an inert 
storage pool that is capable of absorbing considerable amounts of cholesterol. Since the 
physical properties of cholesteryl esters are not conducive to the formation of membrane 
bi layers, their concentration in membranes is very low. Therefore, most cholesteryl 
esters are incorporated into lipoproteins or triglyceride rich cytoplasmic droplets. These 
cytoplasmic droplets serve as substrates for CEH and provide a reservoir for mobil ization 
of cholesteryl ester stores. 
Promoters and control of gene expression 
The DNA of a cell has information responsible for the maintenance of that cell 
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and ult imately the entire organism. Genetic information is first transcribed by RNA 
polymerase and then translated into the finished protein product. Cells have developed 
complex systems to regulate these processes at every step. Transcription initiation is a 
complex process involving both protein:DNA and protein:protein interactions. While the 
details of transcription initiation from mRNA encoding genes by RNA polymerase II and 
associated factors are beyond the scope of this dissertation, it should suffice to ment ion 
some of the essential features of this process. Eukaryotic promoters generally consist of 
cis-acting elements close to the transcription initiation site, which help to direct gene 
expression. Many promoters contain a TAT A-box (consensus sequence TAT ANA; 
where N indicates a position that can be occupied by any nucleotide) approximately 30 
bases upstream of the transcription initiation site, which is recognized by the multi­
subunit complex TFIID. Interaction of TFIID with other init iation factors correctly 
positions RNA polymerase on the DNA and allows transcription to proceed. 
Another common promoter element called the CAA T -box (consensus sequence 
CCAAT) is found between -80 and -60 nucleotides upstream of the transcription 
in itiation site for RNA polymerase II. Although not palindromic, this sequence occurs 
naturally in both orientations and is bound by either the CTF/NF- 1 or CP I proteins 
(Pearson et a!, 1 99 1 ,  Dutta et al, 1 990). 
Transcription init iation also occurs from promoters that lack a TAT A-box and/or 
a CAAT -box. These promoters frequently contain another element whose consensus 
sequence is GGGCGG. This sequence called the GC-box binds the positive transcription 
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factor S P  I .  It is functional in either orientation and can be present in one or multiple 
copies. 
In addition to these elements, eukaryotic promoters also contain other cis-acting 
elements that bind different transcription factors and thus finely regulate the expression 
of various genes. Some of the pertinent cis-acting elements and the transcription factors 
that bind them are discussed below. 
Glucocorticoid response element 
Comparison of available sequence information shows the consensus 
glucocorticoid response element (GRE) to be (T/G)GT ACAnnnTGTTCT (Beato, 1 989). 
The GRE is a transcription enhancer because it functions through heterologous promoters 
and in a relat ively position- and orientation-independent manner (Chandler et al, 1 983 ;  
Yamamoto, 1 985) .  A single GRE works when located immediately upstream of the 
TAT A-box, but multiple copies are required when the GRE' s are located at a distance 
(Strahle et al, 1 988) .  There is considerable variation in the number and location of 
GRE's .  The long terminal repeat of the murine mammary tumor virus (MMTV) gene has 
multiple GRE ' s  clustered near the transcription initiation site (Payvar et al, 1 983) .  On 
the other hand, the clustered GRE's  of the tyrosine aminotransferase gene are located 2 .5 
kb fro m  the transcription start site (Jantzen et al, 1 987). The rat phosphoenol pyruvate 
carboxykinase (PEPCK) gene has a complex glucocorticoid response unit (GRU) that 
spans I I  0 base pairs and inc ludes two glucocorticoid receptor binding elements 
designated GR J and GR2 (lmai et al, 1 990), plus two accessory factor binding elements 
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(AF I and AF2). The rat C7H gene also has a similar GRU located 220 base pairs 
upstream of the transcription start site (Crest ani et al, 1 995). 
The c lassical mechanism for glucocorticoid hormone action involves binding of 
the hormone to a cytoplasmic form of the receptor, followed by a conformational change 
("activation" or "transformation") that leads to its intranuclear translocation and binding 
to chromatin. However the steroid-free glucocorticoid receptor binds specifically to the 
GRE of M MTV in vitro. It is possible that upon binding of the hormone, the oligomeric 
complex of glucocorticoid receptor and a 90 kDa heat shock protein dissociates, leaving 
the DNA binding domain of the receptor free to bind to chromatin. One molecule of the 
receptor binds to the TGTTCT half-site of the GRE, and a second molecule then binds to 
the TGT ACA half-site in a cooperative manner. The receptor contacts the DNA through 
two zinc fingers in the DNA binding domain. The amino-terminal finger interacts 
specifically with one half of the GRE, whereas the carboxyl-terminal finger interacts with 
the DNA helix flanking the GRE consensus sequence. Transcription is enhanced, 
presumably by bringing into close proximity the transactivation domain(s) of the receptor 
with one or more components of the initiation complex. 
Thyroid hormone response element 
Unl ike the GRE, much less is known about the thyroid hormone response element 
(TRE). The proposed consensus sequence for the TRE is TCAGGTCA---TGACCTGA 
(Beato, 1 989). The "---" refers to gaps of I to 6 base pairs between the two half sites. 
This consensus sequence contains half palindromes similar to the estrogen response 
element but with different spac ing. 
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Based on amino acid and structural simi larities, the thyroid hormone receptor 
belongs to the class of steroid hormone receptors that regulate gene expression in a l igand 
dependent manner. Similar to the glucocorticoid receptor, the thyroid hormone receptor-
DNA binding is mediated by a conserved sequence motif that is thought to form a tertiary 
structure of loops or "fingers" coordinated by a metal cation like zn+2 . Whi le thyroid 
hormone can up regulate transcription through the TRE, it has also been demonstrated to 
down regulate transcription of several genes including the thyroid-stimulating hormone 
gene (Shupnik et al, 1 985).  The thyroid hormone receptor can bind both TRE as well as 
the c losely related estrogen response element. However, this binding does not result in 
transcriptional activation. Instead it causes a decrease in the level of expression. Since 
the consensus sequence of the TRE has centrally located gaps and the estrogen response 
element is a variant of the TRE with a gap of 3 base pairs, the functional consequence of 
thyroid hormone receptor binding to the estrogen response element is to decrease the 
estrogen-dependent gene expression. Thus the presence or absence of a 3 base pair gap 
in the DNA recognition sequence dictates positive or negative transcriptional control by 
thyroid hormone. 
Phorbol ester response element 
S ince phorbol esters are activators of protein kinase C (PKC), before elaborating 
on phorbol ester response sequences (PRS), I shall briefly discuss the role of 
phosphorylation in the regulation of transcription. Phosphorylation events are post-
translational modifications that affect the activity of various DNA binding proteins. They 
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not only result in a conformational change in the protein but also affect electrostatic 
interactions. There are three main levels of regulation by phosphorylation: 
Transcription factors may be sequestered in the cytoplasm, bound to inhibitory 
proteins. In response to various stimuli ,  the inhibitory protein is phosphorylated and this 
causes dissociation of the transcription factor, which now enters the nucleus and binds 
DNA to regulate transcription. An example of this type of regulation is the 
phosphorylation of the inhibitory protein IKB that causes it to dissociate from complexes 
with other transcription factors, thereby enabling these transcription factors to enter the 
nucleus and bind to chromatin (Hunter and Karin, 1 992). 
Secondly, phosphorylation can also affect the binding activity of transcription 
factors. It can increase binding, as is observed with phosphorylation of the serum 
response factor by casein kinase II ,  or decrease binding activity as seen by 
phosphorylation of c-Myb by the same casein kinase I I  (Hunter and Karin, 1 992; Luscher 
et al, 1 989). 
Finally phosphorylation could affect transactivation events mediated by a 
transcription factor. For example, the cAMP responsive binding protein when 
phosphorylated by protein kinase A in the activation domain leads to an increase in gene 
expression driven by this element (Gonzalez and Montminy, 1 989). 
Phosphorylation events are controlled by kinases, which in turn are controlled by 
receptor initiated signals conveyed by multiple cell signalling pathways. While there are 
several signalling mechanisms, this discussion will be l imited to the protein k inase C 
(PKC) pathway, since phorbol esters are PKC activators. Activation of the PKC pathway 
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is init iated by binding of ligand to receptor in the plasma membrane. Generally the 
receptor is thought to interact next with a specific heterotrimeric G protein (Gq) which 
requires bound GTP for activity. Association of the receptor with Gq causes the a 
subunit to dissociate and interact with the enzyme phosphoinositide-specific 
phospholipase C (PLCy) . PLC cleaves phosphoinositide 4,5-bisphosphate (PIP2) which 
is located in the inner leaflet of the plasma membrane, to generate inositol triphosphate 
(IP3) and diacylglycerol (DAG). Here, the pathway divides into two branches, each of 
which is crit ical to the signal l ing process. IP3. which is water soluble, diffuses into the 
cytosol and causes the release of Ca+2 from the endoplasmic reticulum. This is mediated 
by the binding of IP3 to special Ca+2 channels in the endoplasmic membrane. The initial 
rise in cytosolic calcium levels results in the movement of PKC from the cytosol to the 
cytoplasmic side of the plasma membrane. Secondly, DAG, along with 
phosphotidylserine which is associated with the plasma membrane, can bind to PKC, 
thereby increasing the affinity of the enzyme for calcium and resulting in enzyme 
activation. While calcium ionophores mimic the affects of IP3 ,  phorbol esters mimic the 
affect of DAG. DAG can also be cleaved to produce arachidonic acid, which can either 
be util ized for prostaglandin synthesis or other lipid signalling moieties. After activation 
PKC phosphorylates cellu lar proteins on serine or threonine residues. These proteins 
may themselves further phosphorylate other cellular proteins leading to potentiation of 
the signal. 
The consensus PRS identified in many genes transcriptionally activated by 
phorbol esters is TGACTCA (Deutsch et al, 1 988). It is believed that 4�-phorbol- 1 2-
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myristate- 1 3-acetate (PMA), a phorbol ester, affects transcription through 
phosphorylation of transcription factors like NF-KB, c-Jun and c-Fos. AP- I and AP-2 
can also confer PMA responsiveness. 
Sterol response element 
Sterol response elements (SRE) are sequences found in the 5' -flanking region of 
genes that respond to the levels of sterols in the cell. The consensus sequence for the 
SRE is CACC(C/G)(Crf)AC (Smith et al, 1 988). This element enhances transcription in 
sterol depleted cells and is inactivated when sterols accumulate in the cell. In tissue 
culture cells the most potent inactivators of SRE are oxysterols, which are derivatives of 
cholesterol with additional hydroxy- or keto- groups that enhance their solubility.  SRE is 
also inactivated by cholesterol when it is delivered to cells in low density lipoproteins. 
Two proteins designated sterol regulatory element binding proteins I and 2 
(SREBP- l and 2) bind to SRE- 1 with a nucleotide specificity that precisely matches the 
requirement for sterol regulated transcription (Wang et al, 1 994). SREBP ' s  are members 
of the basic-helix-loop-helix-leucine zipper family of transcription factors. They bind to 
DNA either as homodimers or as heterodimers. DNA binding is mediated by the basic 
region and dimerization is mediated by the helix-loop-helix and leucine zipper structures. 
The basic helix- loop-helix region is preceded by an acidic amino-terminal region which 
is a putative transcription activation domain. 
Three alternatively spl iced forms of SREBP- l have been identified (Kawabe et al, 
1 994). They are called SREBP- l a, SREB- l b  and SREBP- J c .  The three forms show no 
functional difference in SRE- 1 binding or transcriptional activation in transfected cells. 
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No alternative ly spliced forms of SREBP-2 have been identified as yet. SREBP- 1 a and 
SREBP-2 differ from other basic helix- loop-helix zipper proteins in two important 
aspects; firstly they are larger in size, and secondly they fail  to recognize the palindromic 
hexanucleotide sequences that are targets for all other basic helix-loop-helix zipper 
proteins. Instead they recognize the SRE- 1 sequence which contains a direct repeat of 
CAC. 
SREBP- 1 is synthesized as a 1 25 kDa precursor that is bound intrinsically to 
membranes of the nuclear envelope and the endoplasmic reticulum. In sterol depleted 
cells, the precursor is c leaved proteolyt ical ly to generate amino-terminal fragments of 
apparent molecular masses in the range of 66 kDa to 70 kDa that translocate to the 
nucleus and bind to SRE- 1 .  When cells are exposed to regulatory sterols, proteolysis of 
the 1 25 kDa precursor form of SREBP- 1 is interrupted and the amount of the mature 
nuclear form declines due to rapid turnover (Wang et al, 1 994) . 
S RE- 1 sequences have been found in the 5 '  -flanking sequences of genes for the 
LDL receptor (Osborne et al, 1 988), HMGCoAS (Yokoyama et al, 1 993), HMGCoAR 
(Dawson et al, 1 988),  farnesyl diphosphate synthase (Jackson et al, 1 995), squalene 
synthase (Guan et al, 1 995), fatty acid synthase (Bennett et al, 1 99 1 )  and acetyl Co A 
carboxylase ( Kawabe et al, 1 996; Lopez et al, 1 996). In addition to SRE- 1 sequences, 
the promoters for the LDL receptor and HMGCoAR also have sequences that bind to 
positive transcription factors. In the LDL receptor gene the major positive element is the 
nuclear factor S P I  (Sudhof et al, 1 987; Dawson et al, 1 988).  The HMGCoAR promoter 
contains multiple binding sites for proteins in the nuclear factor- ! (NF- I )  family (Gil et 
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al, 1 988) .  These positive e lements are required for the functioning of the SRE- 1 element. 
In the LDL receptor and HMGCoAS promoters, the SRE- 1 acts as a conditional positive 
e lement, enhancing transcription in the absence of sterols. In the HMGCoAR promoter 
the SRE- 1 also acts as a conditional negative element, repressing transcription in the 
presence of sterols. 
Rationale for study 
Cholesterol ester hydrolases are a group of ubiquitous enzymes that are present in 
many tissues and are associated with different functions, depending on location. They 
catalyze the release of free cholesterol and fatty acids from cholesteryl esters, an 
intracellular storage form of cholesterol. The major cholesteryl ester hydrolytic act ivity 
found in rat liver is associated with a unique cytosolic CEH that is appropriately located, 
rationally regulated and capable of mobil izing free cholesterol from cholesteryl ester 
stores. 
Rat l iver cytosolic CEH has been purified to homogeneity. The eDNA for this 
enzyme has been c loned and expressed. The purified enzyme has been extensively 
characterized biochemically and its physiological relevance has been well established. It 
plays a crucial role in the regulation of hepatic levels of free and esterified cholesterol 
along w ith HMGCoA reductase, cholesterol 7a-hydroxylase and acylcoenzyme 
A:cholesterol acyl transferase. While HMGCoA reductase is actively regulated at the 
transcriptional, translational and post-translational modes, cholesterol 7a-hydroxylase is 
primarily regulated at the transcriptional level. CEH has been demonstrated to be 
regulated at the post-translational level by reversible phosphorylat ion. Recently 
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regulation at the transcriptional level was also studied by measuring the steady-state 
mRNA levels under various conditions. 
While most of the data reported to date suggest that CEH is regulated at the 
transcriptional level, there is no direct evidence to support this mode of regulation. 
Therefore, isolation and characterization of the 5' -flanking portion of the CEH gene 
would enable us to understand the regulation of this enzyme at the transcriptional level. 
Specific objectives to be addressed are as follows: 
I .  Using the sequence of the CEH eDNA, isolate and clone the 5 '  -flanking portion 
of the CEH gene. 
2 .  Identify the transcription start site of  the CEH gene. 
3 .  Identify putative cis-acting elements regulating the expression of the CEH gene. 
4. Map regulatory regions in the 5' - flanking portion using reporter gene constructs 
and transient transfection assays in human hepatoblastoma HepG2 cells and 
cultured primary rat hepatocytes. 
5 .  Determine if the two culture systems used in this study have different effects on 
the CEH promoter. 
EXPERIMENTAL PROCEDURES 
Isolation of the rat hepatic CEH promoter 
The PromoterFinder DNA Walking Kit (Clontech) was used to isolate the rat 
hepatic CEH promoter. The kit contains five "l ibraries" of uncloned adaptor-l igated 
genomic DNA fragments. The "libraries were prepared by digesting rat genomic DNA 
with 5 different restriction enzymes that recognize a 6-base site and leave blunt ends, viz. 
EcoR V, Sea I ,  Dra I,  Pvu II and Ssp I .  These fragments were l igated to a 
PromoterFinder adaptor, the unique features of which el iminates non-specific 
amplification among the general population of DNA fragments. A combination of long 
distance PCR, suppression PCR and "touchdown" PCR were then used isolate the 5 ' ­
flanking portion o f  the CEH gene. 
The gene specific primer SEQP8 5 ' - T ACCCCCAAGCTGTGCACGCAGCAAG 
-3 ' ,  corresponding to positions 56 to 3 1  of the rat hepatic CEH eDNA and the anchor 
primer AP I  5 ' -GTAATACGACTCACTATAGGGC-3 ' of the PromoterFinder kit were 
used in a primary PCR with the five different "l ibraries" of genomic DNA as template. 
Primary PCR was carried out in I X Tth PCR reaction buffer (Ciontech), 10 mM each 
dNTP, 25 mM Mg(OAch, 10 11M adaptor primer AP I ,  10 11M gene specific primer 
SEQP8, I 11 1 of Tth (2U/Ill)/ Vent polymerase (2U/!1 1)/Tth Start™ Antibody (2.2 mg/11 l) 
(Ciontech) mixture (20: I :5 ratio respectively) and I 111 of each genomic "library". 
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Thermal cycling parameters were : 7 cycles of 94°C for 25 seconds and 72°C for 4 min, 
32  cycles of 94°C for 25 seconds and 67°C for 4 minutes and then a 4 minute extension 
at 67°C after the final cycle. 
Primary PCR products were diluted I to 50. One 1-1 1 of the diluted products were 
used as template in a secondary PCR with nested gene specific primer PAS3 5 ' -
GCGCATTGTGGAAGGAACAAATAGCCC-3 ' ,  corresponding t o  CEH eDNA specific 
posit ions 6 to -2 1 in the 5 '  untranslated portion, and nested anchor primer AP2 5 ' -
ACT AT AGGGCACGCGTGGT -3 ' .  The secondary PCR was carried out i n  a buffer of 
the same composition as the primary PCR. Thermal cycling conditions were also 
identical to the primary PCR except that the number of cycles were reduced from 7 to 5 
for the first step and from 32 to 20 for the second step. 
The PCR products (5 1-1 I) were analyzed on a 0.6% agaroserr AE gel along with 
DNA size markers in the form of a I kb ladder. The secondary PCR products from 
"l ibraries" 3 and 4 were T A-cloned into pGEMT -Easy vector (Promega) and sequenced 
by the Dye Terminator Cycle Sequencing System. 
Construction of rat CEH promoter/luciferase reporter genes 
In order to clone the full  length promoter into the luciferase reporter vector pGL3-
Basic (Promega), PCR was performed with the primer PAS5Bglll 5 ' -
gcaagatctGATGACAGAAAAGCTCTC - 3 '  (upper case letters indicate gene sequence), 
bearing a Bgl II restriction site (underlined) and corresponding to position -37 upstream 
of the init iation ATG codon, and anchor primer AP2 which has a Mlu I restriction site. 
The 1 3 1 7  bp PCR product was then cloned into the Bgl 11-Miu I sites of pGL3-Basic to 
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give p- 1 3 1 7Luc. The remaining constructs were obtained by generation of unidirectional 
nested deletion breakpoints in p- 1 3 1 7Luc with Exonuclease III (Exo III) which can digest 
DNA from one end at a uniform rate (Henikoff, 1 987). Briefly, p- 1 3 1 7Luc was cut with 
Kpn I, to generate 3' overhangs resistant to Exo III digestion, and M lu I ,  to generate 5 '  
overhangs susceptible t o  digestion b y  Exo III (Fig.2).  The Kpn I-Miu I cut p- 1 3 1 7Luc 
was then digested with Exo III at 30°C. Aliquots were removed at I minute intervals , 
fo llowed by digestion of single stranded ends with S I nuclease. The ends were fil led 
with KJenow fragment of DNA polymerase, religated with T4 DNA ligase and 
transformed into TOP I OF' cells. All plasmids were verified by restriction digestion 
analysis and sequencing. They were purified by double banding in cesium chloride 
gradients or with Qiagen columns (Qiagen) as per manufacturers instructions. 
Identification of transcription start site 
Primer extension analysis was performed to identify the transcription start site. 
The CEH eDNA specific primer PAS3 was radiolabelled in I X  T4 polynucleotide kinase 
buffer with 3 J.!l of [y-32P] ATP (at 3000 Cilmmol, 1 0  mCi/ml) and I 11 1 of T4 
polynucleotide kinase (8- 1 0 U/J.!I) at 37°C for I 0 min. The T4 polynuc leotide kinase was 
then inactivated by heating to 90°C for 2 min. The radio labelled primer ( I  pmol) was 
annealed to rat liver total RNA ( 1 5  Jlg), prepared by cesium chloride density 
centrifugation (Chirgwin et al), in I X  AMY primer extension buffer ( 1 00 mM Tris-HCI, 
pH 8.3, 1 00 mM KCI, 20 mM MgCh, 20 mM OTT, 2 mM each dNTP, I mM 
spermidine) with 40 � sodium pyrophosphate at 58°C for 20 min. The mixture was 
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Figure2. Strategy for generation of 5 '  deletion constructs of rat CEH promoter!luciferase 
reporter genes from p- 1 3 1 7Luc. The shaded region corresponds to the 1 3 1 7 bp 5 ' ­
flanking portion of the rat CEH gene cloned into pGL3-Basic. The fu l l-length construct 
p- 1 3 1 7Luc was digested with Kpn I and Mlu I to generate 3' and 5 '  overhangs 
respectively. The Kpn I-Mlu I cut p- 1 3 1 7Luc was digested with Exonuclease III at 30°C. 
Aliquots were removed at  I min intervals followed by treatment with S I nuclease, 
Klenow fragment of DNA polymerase and T4 DNA l igase as explained in Experimental 
Procedures to obtain the 5' deletion constructs. 
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allowed to  cool at  room temperature for 1 0  min. The primer was then extended by AMY 
reverse transcriptase ( 1 . 3 U) for 30 min. at 42°C. Primer extension products were 
analyzed on an 8% denaturing polyacrylamide gel fol lowed by autoradiography for 1 6  
hrs. Radiolabelled standards were used to determine the size of the primer extension 
products. 
Culture of human hepatoblastoma HepG2 cells 
Human hepatoblastoma HepG2 cells were grown in 75 cm2 tissue culture flasks in 
Minimal Essential Medium containing L-glutamine (0.292 mg/ml),  non-essential amino 
acids ( I X),  sodium pyruvate (0. 1 1 mg/ml), penicillin ( 1 00 U/ml), streptomycin ( 1 00 
Jlglml) and 1 0% heat inactivated fetal bovine serum at 37°C in a humidified incubator in 
the presence of 5 %  C02 . Cells were seeded in 35 mm dishes with 2 ml of medium and 
grown to confluence. Medium was changed every two days until the cells were 
confluent. These cells were then used for transient transfect ion analysis. 
Isolation and culture of primary rat hepatocytes 
Primary rat hepatocytes used in this study were kindly provided by Dr. P. B .  
Hylemon (Dept. o f  M icrobiology, MCVJVCU). Hepatocytes were isolated from male 
Sprague-Dawley rats (250-300 g) using the collagenase perfusion technique of B issel and 
Guzelian ( 1 980). Prior to plating, cells were judged to be > 90% viable using Trypan 
blue exclusion. Parenchymal cells (8 .5x l 05) were plated in 1 .5 ml of Will iam' s E 
medium containing L-thyroxine ( I  J.1 M),  dexamethasone (50 nM), penic il l in ( I  00 U/ml) 
and 1 0% fetal calf serum in 35 mm Primaria culture dishes (Falcon) at 37°C in a 5% C02 
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atmosphere. After a 6 hr. attachment period, the hepatocytes were used for transient 
transfect ion analysis. 
Transient transfections 
Both HepG2 cells and the primary rat hepatocytes were transiently transfected by 
the calcium-phosphate DNA coprecipitation technique (Graham and van der Eb, 1 973) 
with the MBS mammalian transfect ion kit  (Stratagene). Specifically, 2.0 f.lg of test 
plasmid and 0.5 f.lg of pCMVB, an internal standard for the normalization of transfection 
efficiency, were incubated at room temperature for I 0-20 min. with CaCb (0. 1 25 mM) 
and BBS (N,N-bis(2-hydroxyethyl)-2-aminoethanesulfonic acid and buffered saline, pH 
6.95).  Culture medium in the dishes were replaced with 2 ml of fresh medium containing 
6% modified bovine serum instead of 1 0% fetal calf serum. Following addition of DNA 
suspension, cells were incubated for 3 hrs at 35°C under 3% C02. They were then 
washed three times w ith phosphate-buffered saline (PBS) and refed with appropriate 
serum-free medium with the indicated concentration of agent or vehicle. Dexamethasone 
was reconstituted in 1 00% ethanol. L-thyroxine was dissolved in a solution containing 
70% ethanol and 1 5% 6N NaOH. The solution was vortexed well and kept in a 37°C 
water bath for I 0 min . .  Fetal calf serum ( 1 5%) was then added prior to use. PMA was 
reconstituted in I 00% DMSO. Mevalonolactone and squalestatin were reconstituted in 
water. Squalestatin was kindly provided by Glaxo Research Group, Middlesex, United 
Kingdom, UB6 OHE. Media containing dexamethasone, L-thyroxine and PMA were 
replaced after 20 hrs . .  Transfected cells were incubated at 37°C under 5% C02 for 
different periods of time as indicated in the figure legends. 
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Reporter enzyme assays 
After the incubation period, both HepG2 cells and primary rat hepatocytes were 
washed twice w ith PBS ,  lysed and harvested with 200-300 11 1 of reporter lysis buffer as 
per manufacturers instructions (Promega). Luciferase activity was assayed by mixing 
room temperature luc iferase assay reagent ( 1 00 fl l) to cell extracts (5-20 fl l) also at room 
temperature in a luminometer (Lumat LB950 1 ,  Berthold) (Wood, 1 99 1 )  and measuring 
total light emission during the initial 20 seconds of the reaction. Luciferase act ivity was 
calculated as relative light units (RLU) per mg of protein. B-galactosidase activity was 
measured in 50- 1 00 11 1 of lysate using o-nitrophenyl B-D-galactopyranoside as substrate 
(Nielsen et al, 1 983) .  The product was detected by measuring the absorbance at 420 nm 
in a spectrophotometer. B-galactosidase activity was expressed as units (nmols of o­
nitrophenoVmin./mg protein). Protein concentrations were determined using the Pierce 
BCA reagent (Smith et al, 1 985) .  Luciferase activity was normalized, for inter-assay 
variabi l it ies due to transfection efficiency and extract collection, by dividing the 
luciferase activity by the B-galactosidase activity. 
Statistical analysis 
Data was analyzed for statistically  significant differences by Student 's  t-test and 
p<O.O I was considered significant. 
RESULTS 
Cloning of the rat CEH promoter 
In order to isolate the promoter for the rat CEH gene, we used the PromoterFinder 
DNA Walking Kit (Ciontech). This kit contains five "libraries" of uncloned adaptor­
l igated rat genomic DNA fragments. A combination of long-distance PCR, suppression 
PCR and "touchdown" PCR were used to isolate the 5"-flanking portion of the CEH 
gene. The primary PCR with primers SEQP8 and AP I  (see experimental procedures) 
yielded products ranging from 250 bp to 4 kb in all five "libraries" (Fig .3). Primary PCR 
products were diluted and used as template for a secondary PCR with nested primers 
PAS3 and AP2 (see experimental procedures). Libraries 3 and 4 gave approximately 1 . 3 
kb and 400 bp products respectively (Fig.4 ), in addition to other smaller size products. 
The 1 .3 kb and 400 bp pieces were then T A-cloned into pGEMT -Easy vector and 
sequenced w ith the universal T7 and SP6 primers. The 1 . 3 kb product from l ibrary 3 
overlapped w ith the 400 bp product from library 4 and was identical to it in sequence. 
Analysis of this sequence revealed the presence of several putative cis-acting elements in 
the 5' -flanking region upstream from the first ATG codon. These included hormone 
response elements (TRE, GRE, IRS), liver-specific elements (TGT3, HNF) , ubiquitous 
transcription factor binding sites (NF-Y, AP I ,  SP l )  and sterol responsive elements 
(SRE). 
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Figure 3 .  Agarose gel  analysis of PCR products amplified from rat PromoterFinder 
l ibraries using anchor primer AP I  and eDNA specific primer SEQP8. Primary PCR was 
performed using the protocol for the PromoterFinder kit as explained in Experimental 
Procedures. Lanes 1 -3 ,  5 and 6 correspond to PCR products amplified from libraries I ,  2,  
3 ,  4 and 5 respectively.  Lane 4 i s  a I kb DNA ladder (GIBCO BRL). 
3 7  
1 2 3 4 5 6 
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Figure 4. Agarose g e l  analysis o f  PCR products amplified from rat PromoterFinder 
l ibraries using anchor primer AP2 and nested eDNA specific primer PAS 3 .  Secondary 
PCR was performed using the protocol for the PromoterFinder kit as explained in 
Experimental Procedures. Lanes 1 ,  2 and 4 correspond to secondary PCR products 
amplified from l ibraries 3, 4 and 5 respectively. Lane 3 is a 1 kb DNA ladder (GIBCO 
BRL). 
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Figure 5. Nucleotide sequence of the rat CEH promoter. The DNA sequence shown 
contains 1 3 1 7  nucleotides of 5 ' -flanking DNA upstream of the ATG initiation codon. 
B ases in lower case are identical to the reported CEH eDNA sequence. The transcription 
start site identified by primer extension analysis of total l iver RNA (shown in Fig. 6) is 
indicated by an asterisk (*) .  Putative transcription factor binding sites are either 
underlined or boxed. Sequence identity of the SRE- 1 elements to the consensus SRE- 1 
sequence are indicated. AP I :  activator protein I ;  SRE- 1 :  sterol response element- ! ;  
HRE: hormone response element ; NF-Y: nuclear factor-Y ; CIEBP: CCAAT/ enhancer 
binding protein ; PRS : phorbol ester response sequence ; IRS : insu lin response sequence ; 
GRE: glucocorticoid response element ; HNF3 : hepatocyte nuclear factor 3 .  
4 1  
HNF3 APl 
- 1 3 1 7  AAACAATAAAGGAAGTCTTAGCAAACATAAAGGATTGATTAACTAAATAT 
- 1 2 6 7 AAAACG TACAATAAT TTCTTTCAT TGTGCTAGT TCTTAAGGGAATAAAAC 
GRE / IRS / HNF3 
- 1 2 1 7 CAGAAAAACAAGAAAAATCTGTAGAAATGGAGACTGAACAATATAATTCA 
- 1 1 6 7 CAATGAACAGC GATTCACT GAAGAAATAGGGGAAAGGGAGGGTTGTAAAA 
- 1 1 1 7 TTCCTTAAGTGAAATAAGAACAGAAATACCGCATATAGGACTGAGATAAA 
- 1 0 6 7 ACAAAAGTTGTTCTGGGGGAAAT TCTCTATCATGACCATCTACAGTCTTA 
APl 
- 1 0 1 7  TGTCTTGAAGAAGACATAAT TATGCATCAAAGGGAC T TAAATTCACAGAA 
- 9 6 7 TAGTAC CTCCCTGGGCTGTAGAATACTTAT TAGTTTATCAGCTCATGGAA 
- 9 1 7  AT T T T T CCAAAATAGATAAGTTGAAGAGAT TTGATCT TAAAGGAACTAAA 
C/EBP 
- 8 6 7 GATTCCTAAAAATGAAGCAAATGATGTAGTAATGCATCCAGAGAACTTAA 
GRE / IRS / PRS 
- 8 1 7 AAATAAGTGGT TGGGTAAAACAACCAAATACACAACAGGGGAATGAAAAG 
- 7 6 7  AGGTAGCCATACACAAAAGCATGAAGAGGCTACACTGTTGGAACAGGCTA 
- 7 1 7  GCCAGCAATTCCAGAGACACACCACTTTGCTGTACAT TGTGCAT TCCCAC 
- 6 6 7  GAAGAGAGAGGCCATGTACTTCAGTAAATGTTTGAAGAATCAGT GCACAA 
- 6 1 7  G TACATT CATGGAT TATGAGGTGCCAGTAGAGTTTGTT TACCATATAAAC 
- 5 6 7  G T TATGTCCAAAGGTTCTTTCTCTGAGAGGTAAACTTCCT TGAGCCTGAG 
- 5 1 7  TATGCACCTTGCCTAGCCAAGTCACTTGACAGGAATACTGTGAAGATAAT 
- 4 6 7 T TAAGAATCGTCTGAAGGTCTG TAGGTGGTGAGGTTTCTTCCTAACT TGA 
- 4 1 7  GAATATGGAT TCTAGGAAATGCCAGTCCCAGAGAGGCTGTGAGAAATGTG 
- 3 6 7 T T CTCAC T TCCCATCTGAGCAGAGTGGGAATGAGAGGTATTCTAATATGT 
IRS / PRS SREl 7 / 8  
- 3 1 7  TCATCT T T GTAAAAGGACCCCAGACCAACCCT TGCCACTAAC TGCAGGCA 
PRS 
- 2 6 7  GCTGCCTGCTGCTGTCTGCTCTTGAGAGTTCAAGAGCAT T GAATTGAGGT 
C/EBP 
- 2 1 7  GAGAGTGCTGGAGGGAAAACTGCT TATGTAAGAAGCTGTTGGATGAGTTT 
SREl 6/8 HRE APl APl HRE 
- 1 6 7 CTAGCCfC T TG�T T A AT TG TACTGAC�GTTCApATAAAAGTG 
SPl SRE 
- 1 1 7 GGTAAACTCTTGGTG T CTT GAGATCCCAACTGGCACCCAGAGA 
* 
- 6 7  GCTCTTTGGAAGGGAGAGCTTTTCTGTCATCTTAAATTAC a t c t gt gggc 
Met Arg 
- 1 7 t a t t t g t t cc t t c c a c a a t g c g c  
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Fig.5 shows the nucleotide sequence of the cloned 1 . 3 kb of the promoter for the rat CEH 
gene as well as some of the putative cis-acting elements. 
Primer Extension Analysis 
Primer extension analysis was performed to identify the transcription start site. 
The CEH eDNA specific primer PAS3 was radiolabelled with [y-32P] ATP and annealed 
to rat l iver total RNA ( 1 5  llg) .  The primer was extended with AMY reverse transcriptase 
( 1 . 3 U) for 30 min. at 42°C. The primer extension products were analyzed on an 8% 
denaturing polyacrylamide ge l  fo llowed by autoradiography for 16  hrs. (Fig .6 ,  lane 2) .  
Radiolabelled standards were used to  determine the size of  the primer extension product 
( lane I ) . The primer by itself ( lane 3) did not give any product. However the primer in 
the presence of RNA gave a single 66 bp product. Comparison of the length of this 
product to the DNA sequence of the 5 '  -flanking region allowed the approximate 
posit ioning of the 5' end of the CEH mRNA at nucleotide -60 upstream from the 
in itiation ATG codon (Fig .5) .  Although no canonical TAT A-box sequences were found 
around the transcription start site, a consensus GC-box which binds the positi ve 
transcription factor SP I ,  was found 35 bases upstream from the start site (Fig .5)  
Generation of rat CEH promoterlluciferase chimeric genes 
About 1 . 3 kb of the promoter was cloned into the luciferase reporter vector pGL3-
B asic as detailed in Experimental Procedures, to generate p- 1 3 1 7Luc. The remaining 
constructs were obtained by generation of unidirectional nested deletion breakpoints in p-
1 3 1 7Luc w ith Exonuclease III. Fig.7 shows the products generated by this procedure. 
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Figure 6 .  Determination of transcription start site of rat CEH gene by primer extension 
analysis. Radio labelled primer PAS3 corresponding to regions 6 to -2 1 of the published 
eDNA sequence was annealed to total l iver RNA ( 1 5  IJ.g) and extended w ith  AMY 
reverse transcriptase ( 1 . 3 U) as explained in Experimental Procedures. DNA size 
markers are shown in lane l .  The primer extension product corresponding to 60 
nucleotides upstream of the ATG initiation codon is shown in lane 2. Radiolabelled 
primer by itself is shown in lane 3 .  
66 bp -
40 bp -
24 bp -
1 2 
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Figure 7. Agarose gel analysis of deletion products obtained by digestion of p- 1 3 1 7Luc 
by Exonuclease III for generation of rat CEH promoterlluciferase chimeric genes. The 
ful l  length construct p- 1 3 1 7Luc (lane 1 )  was digested with Exonuclease III as explained 
in Experimental Procedures. Aliquots removed at 1 min intervals were run on a 0 .8% 
agarose gel  ( lanes 2- 1 1  ) .  S ize of the deleted products were estimated by comparison to a 
1 kb DNA ladder (GIBCO BRL). 
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Aliquots removed at I min. intervals were run on a 0.8% agarose gel along with 
l inearized p- 1 3 1 7Luc (Fig.7,  lane 1 ) . A I kb DNA ladder was run on the gel in order to 
estimate the size of the products obtained. These products were re-l igated and 
transformed into TOP I OF' cells. The plasmjds obtained were digested with restriction 
enzymes and sequenced with universal T7 and SP6 sequencing primers to deterrrune the 
exact position of the breakpoint. They were then purified by double banding in cesium 
chloride or with Qiagen columns. 
Promoter activity in HepG2 ceUs 
Determination of basal CEH promoter activity 
To deterrrune the basal promoter activity of the rat CEH gene, confluent HepG2 
cells were transfected with CEH promoter/luciferase chimeric genes shown in Fig .8 .  As 
shown in Fig.9 ful l - length and deletion clones were more active than the promoter-less 
pGL3-Basic by itself. CEH/luciferase chimeric genes downstream of, and including p-
599Luc increased luciferase reporter activity 1 .6 to 2 fold as compared to the longest 
construct p- 1 3 1 7Luc. This suggests that positive cis-acting elements are located 
downstream of nt-599 and repressor sequences upstream of nt-599. 
Effect of dexamethasone on CEH promoter activity 
Previous studies have shown that glucocorticoids can either stimulate or inhibit 
CEH activity when administered in vivo (Gandarias et al, 1 984; Grogan et al, 1 99 1  ). In 
cu ltured primary rat hepatocytes, dexamethasone was required to maintain steady-state 
CEH mRNA levels (Ghosh et al, 1 997 ; manuscript submitted). When HepG2 cells were 
transfected w ith p- 1 3 1 7Luc and treated with increasing concentrations of dexamethasone, 
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Figure 8 .  Il lustration of rat CEH/luc iferase chimeric genes used in this study. Deletion 
c lones were generated by PCR or by Exonuclease III digestion as described in 
Experimental Procedures. Numbers are relative to the ATG initiation codon of the CEH 
eDNA. 
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Figure 9. Basal promoter activity of the rat CEH/luc iferase chimeric genes transfected 
into HepG2 cells. Confluent HepG2 cultures were transfected as described under 
Experimental Procedures and incubated for 40 hrs. in serum free medium. At the end of 
the incubation, cells were harvested and reporter enzyme activities were determined as 
described. Normalized promoter activities are expressed as percentage of control (pGL3-
B asic) and represent the mean ± S. E. M. of 3 independent determinations; (*) indicates 
difference at p<O.OO I .  
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Figure 1 0. Effect of dexamethasone on the promoter activity of the CEH gene in HepG2 
cells. (A) Confluent HepG2 cultures were transfected with p- 1 3 1 7Luc and incubated for 
40 hrs. in serum free medium containing increasing concentrations of dexamethasone. 
Results are expressed as the ratio of luciferase and �-galactosidase activities and 
represent the mean ± S. E. M. of 3 independent determinations. Basal activity of p-
1 3 1 7Luc in the absence of dexamethasone was 1 453 RLU/mU �-galactosidase. (B) 
Confluent HepG2 cultures were transfected with the indicated rat CEH/luciferase 
chimeric genes and incubated for 40 hrs. in serum free medium containing either 0. 1 11M 
dexamethasone in ethanol or ethanol alone. Normalized promoter activities are expressed 
as percentage of control and represent the mean ± S. E. M. of 3 independent 
determinat ions; (*)  indicates difference at p<O.OO I .  
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promoter activity increased approximately 4.5 fo ld at 0. 1 f.!M dexamethasone (Fig . ! OA). 
In order to map the regions that respond to dexamethasone, reporter activity of each 
construct was measured in the presence of 0. 1 f.!M dexamethasone (Fig. I OB) .  Deletion of 
the promoter to nt- 1 1 90 eliminated the induction observed with the full-length construct. 
Further deletion down to nt-859 restored the activation to 2.4 fo ld. However the 
remaining constructs did not show any induction by dexamethasone suggest ing that two 
regions mediate the g lucocorticoid effect, one located between nt- 1 3 1 7  and nt- 1 1 90 and 
the other between nt-859 and nt-540. 
Regulation of CEH promoter activity by thyroid hormones 
Earlier work from this laboratory showed that L-thyroxine (T4) was required in 
conjunction w ith dexamethasone to maintain steady-state CEH mRNA levels in cu ltured 
rat primary hepatocytes (Ghosh et al, 1 997; manuscript submitted). Hoekman et al 
( 1 993) reported that the C7aH gene is activated by T4. Karam and Chiang also observed 
that T4 increases C7aH mRNA levels in HepG2 cells. HMGCoAR mRNA also 
increased in the presence of T4 although this increase resulted from stabilization of the 
mRNA rather than increased transcription (S imonet and Ness, 1 989). Therefore, we 
tested the effect of L-thyroxine on the transcriptional act ivity of the CEH promoter. As 
shown in Fig. I I  A, T4 stimulated the promoter activity of p- 1 3 1 7Luc at a concentration 
as low as 0.0 I f.!M with maximal effect ( 4 fold) at 0.0 I - 1 .0 f.! M .  T4 stimulated the 
activity of all the deletion clones tested except for p- 1 1 90Luc, for which the activity 
stayed at basal levels (Fig. ! !  B) .  Therefore, two regions respond to T4, one between nt-
1 3 1 7  and nt- 1 1 90 and the other between nt-226 and nt-37. 
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Figure I I . Effect of L-thyroxine on the promoter activity of the rat CEH gene in HepG2 
cells. (A) Confluent cultures of HepG2 cells were transfected with p- 1 3 1 7Luc and 
incubated for 40 hrs. in serum free media containing increasing concentrations of L­
Thyroxine. The results are expressed as the ratio of luciferase and �-galactosidase 
activities and represent the mean ± S. E. M. of 3 independent determinations. B asal 
activity of p- 1 3 1 7Luc in the absence of L-thyroxine was 1 453 RLU/mU �-galactosidase. 
(B) Confluent HepG2 cells were transfected with the indicated rat CEH!Iuciferase 
chimeric genes and incubated for 40 hrs. in serum free medium in the presence of 1 .0 11M 
L-Thyroxine or vehicle alone. Results are expressed as the ratio of luciferase and �­
galactosidase activities and represent the mean ± S. E. M. of 3 independent 
deterrrtinat ions;  (*)  indicates difference at p<O.OO I .  
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Effect of phorbol esters on the CEH promoter activity 
Previous studies from this laboratory have shown that CEH is activated in vitro by 
reversible phosphorylation (Ghosh and Grogan, 1 989). On the other hand, the protein 
kinase C (PKC) activator, 4�-phorbol- 1 2-myristate- 1 3-acetate (PMA), decreased CEH 
mRNA by 49% in cu ltured rat primary hepatocytes (Ghosh et al, 1 997 ; manuscript 
submitted). This maximal decrease was observed after a 6 hr. incubation in PMA. In 
order to determine the involvement of a PKC-mediated signal transduction pathway in 
the regulation of CEH gene transcription, transfection experiments were performed in the 
presence of I !J M  PMA. Since long exposures to PMA depletes PKC activity in cells 
(Young et al, 1 987), a time course experiment was performed to determine the optimal 
incubation time in PMA. When HepG2 cells were transfected with p- 1 3 1 7Luc and 
exposed to I !JM PMA for different periods of time, the promoter activity was decreased 
by 34% after a 6 hr. incubation in PMA (Fig. l 2A) . Further exposure to PMA for 24 hrs. 
caused the promoter activity to increase to 1 60% suggesting that the optimal incubation 
time in PMA was 6 hrs. In order to map the regions that respond to PMA, HepG2 cells 
were transfected with various CEH promoter/luciferase chimeric genes and exposed to 
I !J M  PMA for 6 hrs. As seen in Fig. I 2B,  the promoter activity of all the deletion clones 
except for p-540Luc were repressed. The maximal decrease was observed with p-
4 1 8Luc, the activity of which was only about 36% of control, suggesting the presence of 
negative phorbol ester responsive sequences (PRS) in the region from nt-859 to nt-54 1 ,  
nt-4 1 8  to nt-227 and nt-226 to nt-37 and a positive PRS between nt-540 to nt-4 1 9 . 
Effect of agents that perturb cholesterol metabolism on CEH promoter activity 
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Figure 1 2. Effect of phorbol esters on the promoter activity of the rat CEH/luc iferase 
chimeric genes in HepG2 cells. (A) Confluent HepG2 cells were transfected with p-
1 3 1 7Luc and fed w ith serum free medium containing I IJ.M PMA in DMSO or DMSO 
alone. Cells were harvested at the indicated times and reporter enzyme activities were 
determined. Results are expressed as percentage of control of normalized luciferase 
activity and represent the mean ± S. E. M. of 3 independent observations. (B) Confluent 
HepG2 cells were transfected with the indicated rat CEH/luciferase gene constructs. 
They were incubated in serum free medium with I IJ.M PMA in DMSO or DMSO alone 
for 6 hrs. and then harvested. Normalized promoter activities are expressed as percentage 
of control and represent the mean ± S. E. M. of 3 independent obsevations. (*)  indicates 
difference at p<O.OO I ;  (**)  indicates difference at p<0.005 ; (***)  indicates difference at 
p<O.O l .  
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Perturbations of cellular cholesterol metabolism by agents that increase or decrease levels 
of intracel lular cholesterol have a marked effect on CEH mRNA, protein and act ivity. 
Intravenous infusion of mevalonate, an agent known to increase levels of intracel lular 
cholesterol, caused a compensatory decrease in CEH activity and protein mass (Ghosh et 
al, 1 997; manuscript submitted) . Moreover, lovastatin, a potent competitive inhib itor of 
HMGCoAR, increased CEH mRNA 2 fo ld in cu ltured primary rat hepatocytes (Ghosh et 
al, 1 997 ; manuscript submitted). Therefore, in order to determine the sterol 
responsiveness of the CEH gene, we tested the effect of mevalonate and squalestatin, an 
inhibitor of squalene synthase and cholesterol biosynthesis, on the transcriptional activity 
of the CEH promoter. Mevalonate (2 mM) treatment for 24 hrs. repressed reporter gene 
activity of p- 1 3 1 7Luc and p- 1 1 90Luc to 26% and 1 6% of control respectively (Fig. l 3A) . 
Luciferase reporter activity was restored to basal levels in p-859Luc. However activity of 
p-226Luc was only 43% of control, suggesting that sterol response elements (SRE) are 
present between nt- 1 1 90 and nt-859, nt-4 1 8  and nt-227, and betwen nt-226 and nt-37 .  
S imultaneous treatment for 24 hrs. with 2 mM mevalonate and I 11M squalestatin 
restored the activity of p-226Luc (Fig. I 3B) ,  but failed to bring the activity of p- 1 1 90Luc 
back to basal levels. It therefore appears that strong negative SRE's  may be located 
between nt-226 and nt-37 and a positive S RE may be present between nt-4 1 8  and nt-227 . 
Inasmuch as squalestatin did not reverse the inhibition associated with p- 1 1 90Luc, it is  
possible that the region between nt- 1 1 90 and nt-859 is uniquely responsive to non-sterols.  
The positions of the variuos GRE's,  TRE's,  PRS and SRE ' s  in the rat CEH 
promoter, that were ident ified by transient transfections in human hepatoblastoma HepG2 
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Figure 1 3 . Effect of cholesterol perturbing agents on the promoter activity of rat 
CEH/Iuciferase chimeric genes in HepG2 cells. Confluent HepG2 cultures were 
transfected with the indicated rat CEH/Iuc iferase promoter constructs and incubated for 
24 hrs. in serum free medium in the presence or absence of 2 mM mevalonolactone 
alone, (A) or 2 mM mevalonolactone and I J..lM squalestatin, (B) .  Normalized promoter 
activities are expressed as percentage of control and represent the mean ± S. E. M. of 3 
separate observations ;  (* )  indicates difference at p<O.OO I ;  (**) indicates difference at 
p<0.005;  (*** ) indicates difference at p<O.O J .  
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Figure 1 4. Position of cis-acting elements in the rat CEH promoter identified by transient 
transfect ions in HepG2 cells. This figure shows the approximate positions of the various 
response elements identified in the rat CEH promoter by transient transfections in HepG2 
cells. The mapping of each individual response element is explained in the Results 
section. GRE: glucocorticoid response element ; HRE: hormone response element ; PRS: 
phorbol ester response element ; SRE: sterol response element ; TRE: thyroid hormone 
response e lement. 
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cells, is shown in Fig. 1 4. 
Promoter activity in primary rat hepatocytes 
Determination of basal CEH promoter activity 
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The basal CEH promoter activity in primary rat hepatocytes was determined by 
transfection of cultured hepatocytes with the different CEH promoter/luciferase chimeric 
genes shown in Fig .8 .  As  shown in  Fig. l 5 , fu ll- length and deletion clones were more 
active than the promoter-less pGL3-Basic by itself. The CEH/luc iferase chimeric genes 
downstream of, and including p-599Luc increased luciferase reporter activity 1 .6 to 4 
fold as compared to the longest construct p- 1 3 1 7Luc. This suggests that positive cis­
acting elements may be located downstream of nt-599 and repressor sequences upstream 
of nt-599. 
Effect of dexamethasone on CEH promoter activity 
As shown earlier, dexamethasone at 0. 1 f.!M increased CEH promoter activity in 
HepG2 cells. The same concentration of dexamethasone was also required, in 
conjunction w ith T4 to maintain the CEH steady state mRNA levels in cultured rat 
primary hepatocytes (Ghosh et al, 1 997 ; manuscript submitted) . Moreover, the C7aH 
promoter was maximally responsive to dexamethasone at 0. 1 to 1 .0 f.!M (Crestani et al, 
1 995) .  Therefore, in order to map the regions that respond to dexamethasone in primary 
rat hepatocytes, they were transfected with different CEH promoter/luciferase chimeric 
genes and incubated for 40 hrs in the presence or absence of 0. 1 f.! M dexamethasone 
(Fig. l 6) .  The smallest construct p-226Luc increased luciferase reporter activity 4 .5 fo ld. 
The activity of p-4 1 8Luc was only 1 . 8 fo ld. However p-540Luc also induced promoter 
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Figure 1 5 . B asal promoter activity of the rat CEWluciferase chimeric genes transfected 
into primary rat hepatocytes. Cultured primary rat hepatocytes were transfected as 
described under Experimental Procedures and incubated for 40 hrs. in serum free 
medium. At the end of the incubat ion, cells were harvested and reporter enzyme 
activities were determined as described. Normalized promoter activities are expressed as 
percentage of control (pGL3-Basic) and represent the mean ± S. E. M. of 3 independent 
determinat ions ;  (*) indicates difference at p<O.OO I .  
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Figure 1 6. Effect of dexamethasone on the promoter activity of the CEH gene in primary 
rat hepatocytes. Cultured primary rat hepatocytes were transfected with the indicated rat 
CEH/Iuciferase chimeric genes and incubated for 40 hrs. in serum free medium 
containing either 0. 1 j..LM dexamethasone in ethanol or ethanol alone. Normalized 
promoter activit ies are expressed as percentage of control and represent the mean ± S. E. 
M. of 3 independent determinations; (*) indicates difference at p<O.OO I ;  (**) indicates 
difference at p<0.005. 
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activity to 3 .5  fold of control. S imilarly p- 1 1 90Luc stimulated the promoter activity 4.7 
fo ld. These results suggest that dexamethasone induces CEH promoter activity in 
primary rat hepatocytes through three regions, one located between nt- 1 1 90 and nt-859, 
one between nt-540 and nt-4 1 8  and the third between nt-226 and nt-37. 
Regulation of CEH promoter activity by L-thyroxine 
Previous work from this laboratory showed that T4 ( 1 .0 !J M) was required w ith 
dexamethasone to maintain CEH steady state mRNA levels (Ghosh et al, 1 997; 
manuscript submitted) . As shown earlier T4 stimulated CEH promoter activity in HepG2 
cells at 0.0 1 - 1 .0 !JM.  Therefore we tested the effect of T4 ( 1 .0 !J M) on the 
transcript ional activity of the CEH promoter in primary rat hepatocytes (Fig. 1 7) .  T4 
induced the promoter act ivity of p- 1 1 90 by 2.7 fold. Deleting down to p-859Luc 
decreased the induction to 1 .5 fold. The remaining constructs demonstrated the same 
level of induction as p-859Luc suggesting that two regions mediate the T4 effect in 
hepatocytes, one located between nt- 1 1 90 and nt-859 and the other between nt-226 and 
nt-37. 
Effect of phorbol esters on the CEH promoter activity 
As mentioned before, the PKC activator, PMA, decreased CEH mRNA by 49% in 
rat primary hepatocytes (Ghosh et al, 1 997; manuscript submitted). CEH promoter 
activity was also decreased by 64% in HepG2 cells after a 6 hr incubation in PMA. In 
order to determine the involvement of a PKC-mediated signal transduction pathway in 
the regulation of CEH gene transcript ion in primary rat hepatocytes, transfection 
7 1  
Figure 1 7 . Effect of L-thyroxine on the promoter activity of the rat CEH gene in primary 
rat hepatocytes. Cultured primary rat hepatocytes were transfected with the indicated rat 
CEH/Iuciferase chimeric genes and incubated for 40 hrs. in serum free medium in the 
presence of 1 .0 f.LM L-thyroxine or vehicle alone. Results are expressed as the ratio of 
luciferase and �-galactosidase activities and represent the mean ± S. E. M.  of 3 
independent determinations; (*)  indicates difference at p<O.OO I .  
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experiments were performed in the presence o f  PMA ( I  f1 M ) .  A time course experiment 
was first performed to determine the optimal incubation time in PMA. When primary rat 
hepatocytes were transfected with p- 1 3 1 7Luc and exposed to PMA for different periods 
of time, the promoter activity was decreased by 35% after an 8 hr. incubation in PMA 
(Fig. 1 8A). To determine the PMA responsive regions, hepatocytes were transfected with 
various CEH promoterlluc iferase chimeric genes and exposed to I f1M PMA for 8 hrs. 
As seen in Fig . I 8B only the promoter activity of p- 1 3 1 7Luc was repressed. Therefore a 
negative PRS may be located in the region between nt- 1 3 1 7 and nt- 1 1 90. 
Effect of agents that perturb cholesterol metabolism on CEH promoter activity 
As mentioned before perturbations of cellular cholesterol metabolism have a 
marked affect on CEH mRNA, protein and activity. Therefore, in primary hepatocytes, 
as w ith HepG2 cells, we tested the effect of mevalonate and squalestatin on the 
transcriptional activity of the CEH promoter. Mevalonate (2 mM) treatment for 24 hrs. 
repressed the reporter activity of p- 1 3 1 7Luc to 49% of control (Fig. l 9A). Luciferase 
reporter activity was restored to basal levels in p- 1 1 90Luc. However activity of p-
226Luc was only 74% of control, suggesting that sterol response elements (SRE) are 
present between nt- 1 3 1 7  and nt- 1 1 90 and between nt-226 and nt-37.  Simu ltaneous 
treatment for 24 hrs. with 2 mM mevalonate and I 11M squalestatin restored the activity 
of p-226Luc (Fig. 1 9B) ,  but failed to bring the activity of p- 1 3 1 7Luc back to basal levels. 
It therefore appears that a negative S RE may be located between nt-226 and nt-37 .  
Inasmuch as  squalestatin did not reverse the inhibition associated with p- 1 3 1 7Luc, i t  i s  
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Figure 1 8 . Effect of phorbol esters on the promoter activity of the rat CEH/Iuciferase 
chimeric genes in primary rat hepatocytes. (A) Cultured primary rat hepatocytes were 
transfected with p- 1 3 1 7Luc and fed with serum free medium containing I jlM PMA in 
DMSO or DMSO alone. Cells were harvested at the indicated times and reporter enzyme 
activit ies were determined. Results are expressed as percentage of control of normalized 
luciferase act ivity and represent the mean ± S. E. M. of 3 independent observations. (B) 
Cultured primary rat hepatocytes were transfected with the indicated rat CEH/luciferase 
gene constructs. They were incubated in serum free medium with I jlM PMA in DMSO 
or DMSO alone for 6 hrs.  and then harvested. Normalized promoter activities are 
expressed as percentage of control and represent the mean ± S .  E. M. of 3 independent 
obsevations. (**)  indicates difference at p<0.005. 
1 50 
1 20 
0 90 l... -
c 
0 � 
� 60 e 
30 
0 
p- 1 3 1 7 Luc 
p- 1 1 90Luc 
p-859 Luc 
p-540Luc 
p-4 1 8 Luc 
p-226Luc 
0 
3 
20 40 
A 
4 6 8 
Time ( h rs)  
60 80 1 00 1 20 1 40 
% con trol 
75 
76 
Figure 1 9. Effect of cholesterol perturbing agents on the promoter activity of rat 
CEH/Iuciferase chimeric genes in primary rat hepatocytes. Cultured primary rat 
hepatocytes were transfected with the indicated rat CEH/luciferase promoter constructs 
and incubated for 24 hrs. in serum free medium in the presence or absence of 2 mM 
mevalonolactone alone, (A) or 2 mM mevalonolactone and I 11M squalestatin, (B). 
Normalized promoter activities are expressed as percentage of control and represent the 
mean ± S. E. M. of 3 separate observat ions ; (**)  indicates difference at p<0.005. 
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Figure 20. Positions of cis-acting elements in the rat CEH promoter identified by 
transient transfect ions in primary rat hepatocytes. This figure shows the approximate 
positions of the various response elements identified in the rat CEH promoter by transient 
transfections in primary rat hepatocytes. The mapping of each response element is 
explained in the Results sect ion. GRE: glucocorticoid response element ; PRS : phorbol 
ester response element ; SRE: sterol response element ; TRE: thyroid hormone response 
element. 
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possible that the region between nt- 1 3 1 7 and nt- 1 1 90 is uniquely responsive to non-
sterols. Figure 20 shows the positions of these cis-acting elements in the CEH promoter. 
DISCUSSION 
This dissertation describes the isolation and characterization of the rat neutral 
hepatic CEH promoter. The rat CEH promoter is unusual in that it has no consensus 
TAT A-box sequences immediately upstream of the transcription init iation site. However 
the promoter does have a GC-box sequence, which can bind the positive transcription 
factor S P l  to drive transcription, and an inverted CCAAT box, which can bind another 
positi ve transcription factor NF-Y. In this respect the CEH promoter resembles the 
promoter for the HMGCoAR gene and the human squalene synthase gene, which also 
lack TAT A-box like sequences but utilize several GC-box sequences to drive 
transcription. The upstream regions of the promoter involved in transcriptional 
regulation were also characterized. Two different cel l  l ines were used for this purpose: a 
homologous system of rat primary hepatocytes and a heterologous system consisting of 
human hepatoblastoma HepG2 cells. 
To gain insight into the molecular mechanisms involved in the regulation of CEH, 
an in vitro primary rat hepatocyte cell culture system was optimized in this laboratory by 
Ghosh et al. In  this optimized system, insul in,  dexamethasone (0. 1 !lM) and L-thyroxine 
( 1 .0 11M) were required to maintain CEH mRN A at steady-state levels. The HepG2 cell 
l ine is commonly used to study the regulation of cholesterol homeostasis. Most 
intermediates in the bile acid pathway have been detected in HepG2 cells, and the defects 
8 1  
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previously reported were due to culture conditions. These defects have now been 
resolved. HepG2 cells exhibit an adult/terminal phenotype when grown to confluence 
and retain many cholesterol homeostatic functions (Kelly et al, 1 989; Kosaki et al, 1 993). 
They synthesize apolipoproteins B- 1 00, C-11, C-III, E, A-I, A-I I  and A-IV (Gordon et al, 
1 983 ;  Gordon et al, 1 984; Rash et al, 1 98 1 ;  Tam et al, 1 985;  Zannis et al, 1 98 1  ), express 
functional receptors for low density lipoproteins, high density l ipoproteins, insulin,  
transferrin, estrogen and asialoglycoprotein (Wu et al, 1 984; Hoeg et al, 1 985), 
synthesize and secrete lipoproteins (Rash et al, 1 98 1 ;  Tam et al, 1 985 ;  Zannis et al, 
1 98 1  ), and express sterol-27-hydroxylase, HMGCoAR, lecithin:cholesterol 
acyltransferase and ACAT (Erickson and Fielding, 1 986; Martin et al, 1 993). Hence, this 
cell l ine is also a suitable model in which to study the regulation of CEH. 
The hepatic CEH promoter was characterized both under basal conditions and in 
the presence of various physiological stimuli .  Studies in both cell l ines showed that the 
proximal 599 base sequences of the promoter contains activator elements that are l inked 
to distal repressor regions by a TC-rich hinge located between nt-780 and nt-765 , similar 
to the TC-rich hinge found in the C7H promoter. The promoter also contains putative 
cis-acting elements, including several hormone response half-elements, sterol response 
elements, ubiquitous transcription factor binding sites and l iver specific elements, some 
of which are shown in Fig. 5 .  These putative elements were identified using the GCG 
program (SITED AT A). One l iver-enriched transcription factor, CIEBP 
(CCAAT/enhancer binding protein) putatively binds to the promoter between nt- 1 94 and 
nt- 1 86, and between nt-843 and nt-835, and may be required for the developmental 
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regulation and maintenance of the expression of genes. CEH mRNA, protein and 
enzyme activity have been shown to be developmentally regulated both in male and 
female rats (Natarajan et al, 1 996; Natarajan et al, 1 997). Thus, the presence of putative 
binding sites for C/EBP and possibly DBP (albumin D-site binding protein) supports the 
"establishment v/s maintenance" model proposed in the developmental regulation of 
other l iver-specific genes such as PEPCK (phosphoeneol pyruvate carboxykinase) and 
albumin (Crestani et al, 1 995) .  
In  HepG2 cel ls  the response to glucocorticoids was seen primarily in the distal 5'  
flanking sequences. The activation, by dexamethasone, in the region between nt- 1 3 1 7  
and nt- 1 1 90 was nearly twice that seen in the region between nt-859 and nt-540. This 
region between nt- 1 3 1 7 and nt- 1 1 90 has a sequence similar to the sequence within the 
glucocorticoid response unit (GRU) of the PEPCK gene. The complex GRU of the 
PEPCK gene has 2 glucocorticoid receptor (GR) binding sites and 2 sites recognized by 
accessory factors AF I  and AF2. The sequence in the CEH promoter, 
TTTTGGTCTTTTTGTTCTTTTTAGACATCT, is located between positions - 1 1 85 to -
1 1 56. It contains an imperfect palindrome TCT AGAgatTTTTCT which closely 
resembles the consensus glucocorticoid response element (GRE) 
(T/G)GT ACAnnnTGTTCT, where n stands for any nucleotide. The consensus GRE 
directs the specific binding of the GR to DNA in the promoter region of target genes with 
one molecule of the GR binding to each of the two half-s ites in a cooperative manner. 
The 5 '  portion of this sequence, TCTGGTTTT, located between nt - 1 1 77 and nt - 1 1 85 is 
virtually identical to the recognition sequence TGTGGmT, for accessory factor AF2 in 
84 
the PEPCK promoter. Imai et al showed that proteins other than the GR are required for 
activation of glucocorticoid-inducible genes, and that accessory factors AF I  and AF2 do 
not act in the absence of the two GR binding regions. The AF2 element has also been 
shown to be an insulin response sequence ( IRS) which opposes the dexamethasone 
mediated stimulat ion, both in PEPCK and C7H genes. Although we did not test the 
effect of insul in on the CEH promoter in this study, it has been shown that a minimum of 
24 hrs. incubation of rat primary hepatocytes in insul in containing medium is essential to 
observe the synergistic increase in CEH mRNA by T4 and dexamethasone (Ghosh et al, 
manuscript submitted). Therefore it appears that the CEH gene may also contain a 
complex g lucocorticoid response unit with a glucocorticoid response element, an insul in 
responsive sequence and other sequences that mediate the insulin effect in the distal 
regions of the promoter. 
S imilarly, the region between nt-859 and nt-540 has the sequence 
TGTTGTGTATTTGGTTGTITI at positions -78 1  to -80 1 ,  which could also behave as 
a glucocorticoid response unit and account for the dexamethasone mediated stimulation 
in this region. 
On the other hand, three entirely different glucocorticoid response regions were 
mapped by transient transfections in primary rat hepatocytes. These glucocorticoid 
response regions were located between nt- 1 1 90 and nt-859, between nt-540 and nt-4 1 8  
and between nt-226 and nt-37. The region in the CEH promoter between nt- 1 1 90 and nt-
859 has the sequence TCTTGT between nt - 1 1 0 I and nt - 1 096. This sequence is identical 
to the human glucocorticoid response element 5 (HGRE5; von der Ahe et al, 1 985).  This 
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region also contains another sequence TCCTGA between nt- 1 08 1  and nt- 1 076 which is 
identical to the human glucocorticoid response element 7 (HGRE7; Cato et al, 1 985) .  In 
addition the region between nt-540 and nt-4 1 8  has the sequence TGAAGA between nt-
534 and nt-528 which closely resembles the core sequence of the GRE (TGT AGGA -5 ' )  
reported by Langer and Ostrowski. Finally the region between nt-226 and nt-37 contains 
the sequence GGTACTGACTGTTCA between nt- 1 42 and nt- 1 28 which resembles the 
consensus sequence for the GRE (GGT ACAnnnTGTTCT; Beato, 1 989) 
Thus, it is  evident that while dexamethasone stimulated reporter gene activity in 
both HepG2 cells and primary rat hepatocytes, the glucocorticoid response regions 
mapped were different in each cell l ine. This variation could have arisen due to the 
different cellular context and underscores the importance of a careful evaluation of the 
cellular environment (HepG2 cells v/s cultured primary hepatocytes) and the effect of the 
species (man v/s rat) prior to extrapolating the data to an in vivo condition. 
Thyroid hormones stimulated reporter gene activity in both HepG2 cells and 
primary rat hepatocytes. With HepG2 cel ls, activation regions were mapped between nt-
1 3 1 7  and nt- 1 1 90 and between nt-226 and nt-37.  Both these regions have sequences that 
partial ly  match the consensus type II steroid/thyroid hormone response element 
AG(G/T)TCA, although there were no sequences that exactly matched the consensus 
thyroid hormone response element (TRE) TCAGGTCA---TGACCTGA. Similarly in the 
case of primary rat hepatocytes, activation regions were mapped between nt- 1 1 90 and nt-
859 and between nt-226 and nt-37. The region between nt- 1 1 90 and nt-859 contains a 
sequence that partially matched the consensus type II steroid/thyroid hormone response 
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e lement, but none that exactly matched the consensus TRE. As mentioned before, it has 
been shown that T4, along with insulin and dexamethasone, was essential to maintain 
CEH mRNA in cu ltured primary rat hepatocytes. It has also been shown that the 
expression of several liver specific genes in cultures of primary rat hepatocytes is 
abolished unless hormones are added to serum-free medium. Therefore it appears that 
further studies such as mutational analysis would be essential to identify and map the 
thyroid hormone response element in the CEH promoter. 
The tumor promoter PMA repressed the transcriptional activity of the CEH gene, 
both in HepG2 cells and in primary rat hepatocytes. Whereas PMA is a known activator 
of PKC, long term exposures to PMA cause PKC to be proteolyt ically inactivated (Young 
et al, 1 987) .  A time course experiment was therefore performed to determine the optimal 
incubation time of each cell l ine in PMA. In HepG2 cells maximal inactivation occurred 
after 6 hrs. exposure to PMA. On the other hand, in primary rat hepatocytes a time 
course experiment showed maximal inactivation after 8 hrs. exposure to PMA. With 
HepG2 cells, negative PRS were mapped between nt-859 and nt-54 1 ,  nt-4 1 8  and nt-227, 
and nt-226 and nt-37. A positive PRS was also mapped in the region between nt-540 and 
nt-4 1 9 . However in primary rat hepatocytes, only a single negative PRS was identified 
between nt - 1 3 1 7 and nt - 1 1 90. PMA affects transcription of several genes through 
phosphorylation of transcription factors like c-Jun, c-Fos and NFKB . Jun/Fos 
heterodimers mediate their effects by binding to AP- I like elements. Several AP- I like 
sequences with the invariant half-site TCA and the conserved T-nucleotide that are 
crucial for the binding of Jun!Fos are present between nt-226 and nt-37. The region 
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between nt-4 1 8  and nt-227 also has the sequence TCfTGT that resembles the IRS/PRS 
of both the rat and the hamster C7H gene. As discussed previously, the region between 
nt-859 and nt-54 1 includes the sequence TGTTGTGTATTTGGTTGTTTI that resembles 
the IRS/PRS of the PEPCK gene (Imai et al, 1 990). These sites could therefore account 
for the effects observed with PMA in HepG2 cells. 
S imilarly the region between nt- 1 3 1 7  and nt- 1 1 90 has an AP- I like sequence 
TGATTAA between nt- 1 282 and nt- 1 276 that could confer PMA responsiveness in 
primary rat hepatocytes. This region also includes the sequence, 
TTTTGGTCTTTTTGTTCTTTTTAGACATCT located between nt- 1 1 85 and nt- 1 1 56, 
that resembles the IRS/PRS of the PEPCK gene (O'Brien et al, 1 99 1 )  as well as the 
IRStrGT4/HNF3 of the C7H gene (Crestani et al, 1 995). Thus it appears that signal 
transducing agents p lay a significant role in the transcriptional regulation of the CEH 
gene. Moreover, bile acids have been reported to down-regulate the C7H gene 
transcription, partly through the PKC signal transduction pathway (Stravitz et al, 1 995).  
It would be reasonable to postulate that the CEH gene is regulated in a similar fashion by 
bile acids, especially since it has been shown that taurocholate suppresses CEH mRNA 
levels in primary rat hepatocytes (Ghosh et al, 1 997 ; manuscript submitted) 
In this study known cholesterol perturbing agents were used to alter intracellular 
cholesterol levels in HepG2 cells and in primary rat hepatocytes. The agents used were 
mevalanolactone and squalestatin. Cholesterol is the major product of the mevalonate 
pathway. In addition several biologically important non-sterol products such as 
isopentenyl adenine, dolichol, coenzyme Q, heme A and prenylated proteins are also 
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produced from mevalonate (Goldstein and Brown, 1 990). Squalestatin, also called 
zaragozic acid A, is a competitive inhibitor of squalene synthase at picomolar 
concentrations and effectively lowers serum cholesterol in marmosets (Baxter et al, 
1 992). Squalene synthase catalyzes the committed step of cholesterol biosynthesis 
(Bruenger and Ril l ing,  1 986). This step is the first on the pathway to cholesterol after it 
branches to the various non-sterol products mentioned above. Therefore inhibition of 
squalene synthase by squalestatin selectively lowers only sterol end products, but does 
not deprive the cell of important non-sterol products. Sterol and non-sterol products 
regulate the expression of proteins involved in cholesterol homeostasis at multiple levels 
including transcription, translation and protein degradation. In general, sterols regulate 
gene expression at the level of transcription, while non-sterols act at the level of 
translat ion. 
Mevalonate has been shown to decrease HMGCoAR transcription rates 
(Goldstein and B rown, 1 990) and both CEH (Ghosh et al, 1 997; manuscript submitted) 
and HMGCoAR steady-state mRNA levels (Goldstein and Brown, 1 990). In primary rat 
hepatocytes cultured in serum-free medium, squalestatin decreased C7H specific activity 
to undetectable levels and also decreased its steady-state mRNA levels and 
transcriptional activity (Kinchel et al, 1 995).  In the present study, mevalonate decreased 
CEH promoter activity by 57% for the smallest construct, p-226Luc and it also decreased 
the activity of p- 1 1 90Luc by 84% in HepG2 cells. In contrast, treatment w ith 
squalestatin along with mevalonate, restored the promoter activity of p-226Luc. 
Therefore functional sterol responsive sequences must be present between nt-226 and nt-
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37 .  Two SRE- 1 like sequences are present between nt-226 and nt-37, one being 
CACCGAAC which has a 7/8 base match and the other being CACCGATC which has a 
6/8 base match with the consensus SRE- 1 sequence CACC(C/G)(C/T)AC, found in the 
promoters of HMGCoAS, HMGCoAR and the LDLR genes (Smith et al, 1 988) .  In 
primary rat hepatocytes, mevalonate decreased CEH promoter activity of p- 1 3 1 7Luc to 
49% of control and that of p-226Luc to 74%. However, treatment with squalestatin, 
along w ith mevalonate, only restored the promoter activity of p-226Luc. Therefore the 
two SRE- 1 elements identified with HepG2 cells, also appear functional in primary rat 
hepatocytes. 
Thus, the CEH gene appears to have functional sterol responsive elements similar 
to those of LDLR, HMGCoAS, HMGCoAR, farnesyl diphosphate synthase, squalene 
syntahse, fatty acid synthase and acetyl CoA carboxylase. These genes not only have 
sterol responsive elements but also different positive promoter elements that are required 
for the S RE ' s  to function. In the LDLR gene, the SRE- 1 is a conditional positive element 
that enhances transcription in the absence of sterols, but not when they are present. The 
S RE- 1 synergizes with two nearby sequences that are relatively weak binding sites for 
the positive transcription factor SP I (Dawson et al, 1 988). In vivo, The SRE- 1 and the 
two S P  1 sequences are all necessary for high level transcription in the absence of sterols. 
In the HMGCoAR promoter, the SRE- 1 sequences actively repress transcription in the 
presence of sterols. The SRE- 1 sequences are located in the midst of a cluster of e ight 
protein binding sites, six of which bind proteins belonging to a family of transcription 
factors designated the CTF and the NF- I group (NF- I ,  nuclear factor- ! ;  CTF, CCAA T-
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binding transcription factor) (Gil et al, 1 988;  Gil et al, 1 988a; Santoro et al, 1 988) .  The 
CEH promoter has potentially both SP l and NF-Y binding sites at nt- 1 04 and nt- 1 46 
respectively, that may be required for the functioning of the SRE.  
The simplest interpretation of  the data suggests the presence of a conditional 
negative e lement in the proximal 226 bases of the CEH promoter. In the presence of 
sterols,  the elements may bind a negative transcription factor (SREBP) that competes for 
binding with the positive transcription factors and thus down-regulates transcription. 
Nevertheless, in  order to determine if these octanucleotides are true sterol regulatory 
elements, it wi l l  be necessary to disrupt these elements by site-directed mutagenesis and 
then test transcription levels in the presence or absence of sterols. 
The region between nt- 1 1 90 and nt-859 in the case of HepG2 cells, and the region 
between nt- 1 3 1 7 and nt- 1 1 90 in the case of primary rat hepatocytes, considerably 
reduced promoter activity in the presence of mevalonate and the activity was not restored 
to control levels by simultaneous treatment with squalestatin. It is possible that this 
region has a cis-acting element that responds to non-sterols in the cell. The existence of a 
non-sterol response e lement and its ability to down-regulate transcription is unique and 
contrary to the w idely  held view that non-sterols only act at the post-translational level. 
Identification of the nature of the non-sterol, the non-sterol response element and its 
putative DNA binding proteins wi l l  enable us to elucidate this novel mechanism of 
regulation. 
In this study the rat CEH promoter was characterized by transient transfect ion 
assays in two different cell l ines. One of the aims of this study was to determine if the 
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culture systems used had different effects on the CEH promoter. The basal CEH 
promoter activity in the human HepG2 cells was similar to that observed in primary rat 
hepatocytes. In the presence of dexamethasone, GRE's in the CEH promotor were 
mapped between nt- 1 3 1 7 and nt- 1 1 90 and between nt- 859 and nt-540 by transient 
transfection assays in human HepG2 cells. However the GRE' s  mapped by transient 
transfection assays in primary rat hepatocytes were located between nt- 1 1 90 to nt-859, 
nt-540 to nt-4 1 8, and between nt-226 to nt-37. The glucocorticoid response sequences 
mapped in these regions were the same, suggesting that the nature of the transcription 
factor invo lved, in this case the glucocorticoid receptor, could account for the differences 
observed in the location of the glucocorticoid response regions. Alternatively, the 
interaction between the transcription factor and the transcript ion initiation complex could 
also influence the rate of transcription of the gene. This, in turn, would depend on the 
nature of the transactivating domain of the transcription factor and its proximity to the 
transcription init iation complex. Phorbol esters are activators of PKC, which in turn 
phosphorylates other proteins. As mentioned earlier, phosphorylation events are post-
translational modifications that affect the activity of DNA binding proteins in different 
ways. Thus depending on the nature of the phosphorylation event, transcription factors 
can be turned "on" or turned "off' .  The kinases involved could also be different in the 
two cell J ines and this in turn could account for the differential effects observed in the 
two cu lture systems. Final ly the SRE identified by transient transfection assays in the 
two cel l  l ines were exactly identical, suggesting that the transcription factor/s that 
respond to the level of sterols in the two cell lines are similar. Thus it appears that a more 
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detailed and specific study would be required to detect differences between a homologous 
culture system and a heterologous culture system. 
It is apparent that coordinate regulation of fatty acid and cholesterol metabolism is 
essential for balanced membrane biosynthesis and turnover, to accommodate metabolic 
fluctuations that occur during normal cellular growth. Moreover, these two important 
l ip ids are simu ltaneously required in the liver for regular, ordered assembly of very low 
density l ipoprotein particles, which deliver their lipid load of cholesterol and fatty acids 
fro m  the l iver to other sites in the body to maintain lipid homeostasis (Brown and 
Goldstein, 1 986) . Therefore, not surprisingly, the genes in these pathways are also 
apparently co-regulated. They share common cis-acting elements and specific regulatory 
proteins that bind to these elements in order to coordinately regulate the expression of 
these genes. An example of such a regulatory sequence is the sterol response element 
(SRE- 1 ) .  As mentioned before, SRE- 1 sequences have been found in the promoters of 
genes that regulate cholesterol metabolism l ike LDLR, HMGCoAR, HMGCoAS, and 
squalene synthase. Moreover, these SRE- 1 sequences have also been identified in the 
promoters of genes that regulate fatty acid metabolism like fatty acid synthase, an 
essential enzyme of fatty acid biosynthesis, acetyl coenzyme A carboxylase, the rate-
contro ll ing enzyme for fatty acid biosynthesis, and hormone sensitive lipase, an enzyme 
that plays a key role in adipocyte lipid metabolism. SREBP- 1 is the regulatory protein 
that binds to the S RE- 1 sequence in humans. The rat equivalent of SREBP- 1 was cloned 
fro m  an adipocyte cDN A expression library (Tontonoz et al. 1 993). The rat SREBP 
mRNA was induced during adipocyte differentiation in cell culture, and so it was named 
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the adipocyte determination- and different iation- dependent factor (ADD 1 ). SREBP- 1 
binds to the SRE- 1 sequence in the promoters of genes involved in cholesterol 
metabolism and regulates cellu lar sterol levels. Moreover, expression of the mRNA's  for 
fatty acid synthase and acetyl coenzyme A carboxylase have been demonstrated to be 
regulated by sterols in a manner similar to genes that encode proteins of cholesterol 
metabolism and ADD 1 is the regulatory protein implicated in the sterol responsiveness of 
these genes. S ince ADD 1 is the rat equivalent of SREBP- 1 ,  it is evident that SREBP-
1 /ADD 1 serves as a direct molecular connection between the regulation of two different 
classes of cellular lipids that are both required for cellular growth and normal lipoprotein 
metabolism. 
As mentioned before, CEH hydrolyzes cholesteryl esters to cholesterol and free 
fatty acids. This enzyme is therefore uniquely capable of regulating this aspect of both 
cholesterol and fatty acid metabolism. In this study we have identified and mapped 
functional S RE- 1 sequences in the 5' flanking portion of the rat CEH gene, to which 
S REBP- 1 or ADD 1 could bind. Presence of these functional SRE- 1 sequences in the 
CEH promoters indicates the importance of this enzyme in regulation of cholesterol 
metabolism. Previously, CEH has been shown to hydrolyze a broad range of substrates 
(Natarajan et al, 1 996a) including cholesteryl esters and triglycerides. In the current 
study we also demonstrated the presence of functional hormone response elements. 
These hormone response elements have been previously ident ified in the promoters of 
genes that regulate fatty acid metabolism. Therefore, considering the ability of this 
enzyme to release free fatty acids from different substrates, and the presence of various 
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hormone response elements in the CEH promoter, similar to those present in the 
promoters of genes that regulate fatty acid metabolism, it is apparent that this enzyme 
could also play a significant role in fatty acid metabolism. 
Thus, while coordinate regulation can be mediated by the involvement of SREBP-
I /  ADD I in the transcriptional control of fatty acid synthesis and cholesterol homeostasis, 
the abi l ity of CEH to release both cholesterol and fatty acids, the broad substrate 
specificity of this enzyme, and the presence of functional sterol response elements and 
hormone response elements in its promoter makes this enzyme a candidate for an 
additional level of coordinate regulation, which in turn could link the two pathways 
together. 
In this dissertation the isolation and regulation of the rat hepatic neutral CEH 
promoter by various physiological stimul i  has been described. It appears that the rat 
CEH gene is regulated by mult iple physiological stimul i  that fine tune the expression of 
the gene. Moreover, due to overlapping consensus sequences in the proximal 226 bases, 
compet ition for binding by transcription factors and their cross talk would eventually 
determine the level of CEH expression. Finally, determination of exact cis-acting 
sequences and the transcription factors that bind to them would enable us to have a 
greater understanding of the transcriptional regulation of the CEH gene. 
LITERATURE CITED 
95 
96 
LITERATURE CITED 
Beato M. 1 989. Gene regulation by steroid hormones. Cell 56:335-344. 
Beg, Z. H., J. A. Stonik, and H. B. Brewer. 1 987. Modulat ion of the enzyme activity of 
3 -hydroxy-3-methyl glutaryl coenzyme A reductase by multiple kinase systems involving 
reversible phosphorylation: a review. Metabolism 36:900-9 1 7 .  
Bennett, M. K., J.  H .  Lopez, H .  B .  Sanchez, and T. F .  Osborne. 1 99 1 .  Sterol 
regulation of fatty acid synthase promoter. J .  Bioi. Chern. 270:25578-25583.  
B issell, D. M. and P. S. Guzelian. 1 980. Phenotypic stabil ity of adult rat hepatocytes in 
primary monolayer culture. Ann. N Y. Acad. Sci. 349:85-98. 
Blackberg, L. and 0. Hernell. 1 993.  B ile salt-stimulated lipase in human milk. 
Evidence that bile salt induces lipid binding and activation via binding to different sites. 
FEBS Lett. 323 : 207-2 1 0. 
Brodt-Eppley, J. and D. Y. Hui. 1 994. Dietary regulation of cholesterol esterase mRNA 
level in rat pancreas. J .  Lipid Res. 35 :27-35. 
Brown, M. S.  and j. L. Goldstein. 1 986. A receptor-mediated pathway for cholesterol 
homeostasis. Science 232:34-47 . 
Calame, K. B., L. Gallo, E. Cheriathundam, G. V. Vahouny, and C. R. Treadwell. 
1 97 5 .  Purification and properties of subunits of sterol ester hydrolase from rat pancreas. 
Arch.  B iochem. B iophys. 1 68 : 57-65. 
Camulli, E. A., M. J. Linke, H. L. Brockman, and D. Y. Hui. 1 989. Identity of a 
cytosolic neutral cholesterol esterase in rat liver with the bile salt-stimulated cholesterol 
esterase in rat pancreas. B iochim. B iophys. Acta I 005 : 1 77- 1 82 .  
Chandler, V. L., B. A. Maler, and K.  R.  Yamamoto. 1 983.  DNA sequences bound 
specifically by g lucocorticoid receptor in vitro render a heterologous promoter hormones 
responsive in vivo.  Cell 33 :489-499. 
Chang, C. C. Y., H. Y. Huh, K. M. Cadigan, and T. Y. Chang. 1 993. Molecular 
c loning and functional expression of human acylcoenzyme A:cholesterol acyltransferase 
97 
eDNA in mutant chinese hamster ovary cells. J. B ioi .  Chern. 268 :20747-20755. 
Chiang J. Y. L., and T. P. Yang. 1 992. Cloning and 5' -flanking sequence of a rat 
cholesterol ?a-hydroxylase gene. J. B ioi .  Chern. 266:6467-647 1 .  
Chiang, J. Y. L.,  and D. Stroup. 1 994. Identification of a putative bile acid-responsive 
element in cholesterol ?a-hydroxylase gene promoter. J. Bioi.  Chern. 269 : 1 7502- 1 7507. 
Chin, L., and R. Morin. 1 97 1 .  Purification of a human placental cholesteryl ester 
hydrolase. B iochim. B iophys. Acta 23 1 : 1 94- 1 97. 
Chirgwin, J. M., A. E. Pryzybla, R. J. MacDonald, and W. J. Ratter. 1 979. Isolation 
of bio logical ly active ribonucleic acid from sources enriched in ribonucleases. B iochem. 
1 8 :5294-5299. 
Cook, K. G., R. J. Cothran, J. Snee and S. J. Yeaman. 1 983.  Cytosolic cholesterol 
ester hydrolase from bovine corpus luteum: its purification, identification and 
relationship to hormone sensitive lipase. B iochim. B iophys. Acta 752 :46-53.  
Crestani, M., W. G. Karam, and J. Y. L. Chiang. 1 994. Effects of bile acids and 
steroid/thyroid hormones on the expression of cholesterol ?a-hydroxylase mRNA and the 
CYP7 gene in HepG2 cells. B iochem. Biophys. Res. Commun. 1 98 : 546-553 .  
Crestani, M. ,  D.  Stroup, and J. Y. L .  Chiang. 1 995. Hormonal regulation of the 
cholesterol ?a-hydroxylase gene (CYP7). J. Lipid Res. 36:24 1 9-2432. 
Dawson, P. A., S.  L. Hofmann, D. R. van der Westhuyzen, T. C. Sudhof, M. S. 
Brown, and J. L. Goldstein. 1 988.  Sterol-dependent repression of low density 
lipoprotein receptor promoter mediated by 1 6-base pair sequence adjacent to binding site 
for transcription factor Sp l .  J. Bioi. Chern. 263 :3372-3379. 
Deutsch, P. J., J. P. Hoeffler, J. L. Jameson, and J. F. Habener. 1 988.  Cycl ic AMP 
and phorbol ester-stimulated transcription mediated by similar DNA elements that bind 
distinct proteins. B iochemistry 85 :7922-7926. 
Deykin, D., and D. S. Goodman. 1 962. The hydrolysis of long chain fatty acid esters of 
cholesterol with rat liver enzymes. J. B ioi. Chern. 237:3649-3656. 
Durham, L. A., and W. M. Grogan. 1 982. Temperature sensitivity of cholesterol ester 
hydrolases EC-3. 1 . 1 . 1 3 in the rat testis. Lipids 1 7 :970-975. 
Durham, L. A., and W. M. Grogan. 1 984. Characterizat ion of multiple forms of 
cholesteryl ester hydrolases EC-3 . 1 . 1 . 1 3  in the rat testis. J. B ioi .  Chern. 259 :7433-7438.  
98 
Dutta, A., M. Y. Stoeckle, and H. Hanafusa. 1 990. Serum and v-src increase the level 
of CCAAT -binding factor required for transcription from a retroviral long terminal 
repeat. Genes and Dev. 4 :243-254. 
Erickson S. K., M. A. Shrewsbury, C. Brooks, and D. J. Meyer. 1 980. Rat liver 
ACAT: its regulation in vivo and some of its properties in vitro. J. Lipid Res. 2 1 :930-94 1 .  
Eto, Y., and K. Suzuki. 1 972. Cholesterol esters in developing rat brain: enzymes in 
cholesterol ester metabolism. J .  Neurochem. 1 9: I 09- 1 1 5 . 
Fontaine R. N., C. Y. Carter, and D. Y. Hui. 1 99 1 .  Structure of the rat pancreatic 
cholesterol esterase gene. B iochemistry 30:7008-70 1 4. 
Gallo, L. L., Y. Chiang, G. V. Vahouny, and C. R. Treadwell. 1 980. Localization and 
origin o f  rat intestinal cholesterol esterase by immunocytochemistry. J. Lipid Res. 
2 1 : 537-545. 
Gallo L.  L.  1 98 1 .  Sterol ester hydrolase from rat pancreas. Methods Enzymol 7 1 :664-
674. 
Gandarias, j. M., M. Lacort, M. J. Martinez, M. A. deNicolas, and B. Ochoa. 1 984. 
Effect of sex, ovariectomy and female sex hormones on neutral cholesterol ester 
hydrolase in rat l iver. Exp. Clin. Endocrinol .  84:262-270. 
Gandarias, j. M., M. Lacort, M. J. Martinez, C. J. Fernandez, and B. Ochoa. 1 987. 
Kinetic properties and solubil ization of microsomal cholesterol ester hydrolase from rat 
l iver. Steroids 49:403-4 1 7 .  
Gavey, K .  L., D .  L .  Trujillo, and T .  J .  Scallen. 1 983 .  Evidence for 
phosphorylation/dephosphorylation of rat liver acylcoenzyme A:cholesterol 
acyltransferase. Proc. Nat!. Acad. Sci. USA 80:2 1 7 1 -2 1 74.  
Ghosh, S. ,  and W. M. Grogan. 1 99 1 . Rapid three step purification of a hepatic neutral 
cholesteryl ester hydrolase which is not the pancreatic enzyme. Lipids 26:793-798. 
Ghosh, S., and W. M. Grogan. 1 992. Immunological characterization of neutral 
cholesteryl ester hydrolase from rat liver cytosol. Biochem. Cell. Bioi .  70:800-803. 
Ghosh, S., D. H. Mallonee, P. B. Hylemon, and W. M. Grogan. 1 995. Molecular 
cloning and expression of rat hepatic neutral cholesteryl ester hydrolase. Biochim. 
B iophys. Acta 1 259:305-3 1 2. 
Ghosh, S., and W. M. Grogan. 1 989. Activation of rat liver cholesterol ester hydrolase 
by cAMP-dependent protein kinase and protein kinase C. Lipids 24:733-736. 
99 
Ghosh, S., R. Natarajan, W. M. Pandak, and W. M. Grogan. Submitted for 
publication. Regulation of hepatic neutral cholesteryl ester hydrolase in vivo and in vitro 
by hormones and changes in cholesterol flux. 
Gil, G., T. G. Osborne, J, L. Goldstein, and M. S. Brown. 1 988. Purificat ion of a 
protein doublet that binds to six TGG-containing sequences in the promoter for hamster 
3-hydroxy-3-methyl glutaryl coenzyme A reductase. J. B ioi .  Chern. 
Goldstein, J, L., and M. S. Brown. 1 990. Regulation of the mevalonate pathway. Nature 
343 :425-430. 
Gonzalez, G. A. and M. R. Montminy. 1 989. Cyclic AMP stimulates somatostatin gene 
transcription by phosphorylation of CREB at serine 1 33 .  Cell 59:675-680. 
Goodwin, C. D., B. W. Cooper, and S. Margoles. 1 982. Rat liver cholesterol ?a­
hydroxylase. Modulation of enzyme activity by changes in phosphorylation state. J.  Bioi .  
Chern. 257:4469-44 72. 
Gould R. G. 1 977. In Cholesterol Metabolism and Lipolytic Enzymes (Polonovski J .  ed) 
pp 1 3-38,  Masson, New York. 
Graham, F. L., and A. J, van der Eb. 1 973 .  A new technique for the assay of infectivity 
of human adenovirus 5 DNA. Virology 52 :456-467. 
Grogan, W. M., M. L. Bailey, D. M. Heuman, and z. R. Vlahcevic. 1 99 1 .  Effects of 
perturbations in hepatic free and esterified cholesterol pools on bile acid synthesis, 
cholesterol ?a-hydroxylase, HMGCoA reductase, acyl-CoA:cholesterol acyltransferase 
and cytosolic cho lesteryl ester hydrolase. Lipids 26:907-9 14 .  
Guan, G., G. Jiang, R.  L.  Koch, and I. Schecter. 1 995.  Molecular cloning and 
functional analysis of the promoter of the human squalene synthase gene. J .  B ioi. Chern. 
270:2 1 95 8-2 1 965. 
Hajjar, D. P., C. R. Minick, and S. Fowler. 1 983.  Arterial neutral cholesteryl esterase: 
a hormone sensitive enzyme distinct from lysosomal cholesteryl esterase. J .  B ioi. Chern. 
258 : 1 92- 1 98 .  
Han, J ,  H., C .  Stratowa, and W .  J ,  Rutter. 1 987. Isolation of fu l l  length putative 
lysophospholipase eDNA using improved methods for mRNA isolation and eDNA 
c loning. B iochemistry 26: 1 6 1 7- 1 625. 
Henikoff S. 1987. Unidirectional digestion with Exonuclease III m DNA sequence 
analysis. Methods Enzymol .  1 55 : 1 56- 1 65.  
100 
Hemell, 0. and T. Olivecrona. 1 974. Human milk lipase. II. B ile salt-stimulated lipase. 
B iochim. B iophys. Acta 369:234-244. 
Hoekman M. F. M., J. M. J. Rientjes, J. Twisk, R. J. Planta, H. M. G. Princen, and 
W. H. Mager. 1 993.  Transcriptional regulation of the gene encoding cholesterol ?a­
hydroxylase in the rat. Gene 1 30:2 1 7-223. 
Holm, C., K. L. Svenson, S. Nilson, J. E. Shively, R. S. Sparkes, A. J. Lusis, and M. 
C. Schotz. 1 988.  Hormone-sensitive lipase: sequence expression and chromosomal 
localization to 1 9  cent-q 1 3 . 3 .  Science 24 1 :  1 503- 1 506. 
Holst, L. S., A. M. Hoffman, H. Mulder, F. Sundler, C. Holm, A. Bergh, and G. 
Fredrikson. 1 994. Localization of hormone-sensitive lipase to rat Sertoli cells and its 
expression in developing and degenerating testes. FEBS Lett. 355 : 1 25- 1 30. 
Howles, P. N., C. P. Carter, and D. Y. Hui. 1 996. Dietary free and esterified cholesterol 
absorption in cholesterol esterase (bile salt-stimulated lipase) gene-targeted mice. J .  Bioi. 
Chern. 27 1 :7 1 96-7202. 
Huang, Y .,  and D. Y. Hui. 1 99 1 .  Cholesterol esterase biosynthesis in rat pancreatic 
AR42J cells. Post-transcriptional activation by gastric hormones. J. B ioi .  Chern. 
266:6720-6725. 
Hui, D. Y. and J. A. Kissel. 1 990. Sequence identity between human pancreatic 
cholesterol esterase and bile salt-stimulated milk lipase. FEBS Lett. 276: 1 3 1 - 1 34. 
Hui, D. Y., K. Hayakawa, and J. Oizumi. 1 993. Lipoamidase activity in normal and 
mutagenized pancreatic cholesterol esterase (bile salt-stimulated lipase). B iochem. J. 
29 1 : 65-69. 
Hunter, T., and M. Karin. 1 992. The regulation of transcription by phosphorylat ion. 
Cell 70: 375-387. 
Imai, E., P-E Stromstedt, P. G. Quinn, J. Carlstedt-Duke, J-A. Gustafsson, and D. 
K. Granner. 1 990. Characterization of a complex glucocorticoid response unit in the 
phosphoenolpyruvate carboxykinase gene. Mol. Cell. B ioi .  1 0:47 1 2-47 1 9. 
Jackson, S. M., J. Ericsson, T, F. Osborne, and P. A. Edwards. 1 995. NF-Y has a 
novel role in sterol-dependent transcription of two cholesterogenic genes. J. Bioi. Chern. 
270:2 1 445-2 1 448. 
1 0 1  
Jacobson, P. W., P. W. Wiesenfeld, L. L. Gallo, R. L. Tate, and J. C. Osborne. 1 990. 
Sodium cholate- induced changes in the conformation and activity of rat pancreatic 
cholesterol esterase. J. B ioi .  Chern. 265 :5 1 5-52 1 .  
Jantzen, H-M., U. Strahle, B. Gloss, F. Stewart, W. Schmid, M. Boshart, R. 
Miksicek, and G. Schutz. 1 987. Cooperativity of glucocorticoid response elements 
located far upstream of the tyrosine aminotransferase gene. Cell 49:29-38.  
Jelinek, D., and D. W. Russel. 1 990. Structure of the rat gene encoding cholesterol ?a­
hydroxylase. B iochemjstry 29:778 1 -7785 .  
Kawabe, Y., M. Honda, Y .  Wada, Y .  Yazaki, T .  Suzuki, Y .  Ohba, H. Nahata, A .  
Endo, A.  Matsumoto, H. Hakura, and T .  Kodama. 1 994. Sterol mediated regulation of 
SREBP- 1 a, I b, l c, and SREBP-2 in cu ltured human cells. B iochem. B iophys. Res. 
Commun.  202 : 1 460= 1 467 . 
Kawabe, Y., R. Sato, A. Matsumoto, M. Honda, Y. Wada, Y. Yazaki, T. A. Endo, T. 
Takano, H. Hakura, and T. Kodama. 1 996. Regulation of fatty acid synthase 
expression by cholesterol in human cultured cells. B iochem. B iophys . Res. Commun. 
2 1 9 : 5 1 5 -520. 
Khoo, J. C., E. M. Mahoney, and D. Steinberg. 1 98 1 .  Neutral cholesterol esterase 
activity in macrophages and its enhancement by cyclic AMP-dependent protein kinase. J .  
B ioi .  Chern. 256: 1 2659- 1 266 1 .  
Klauda, H .  C., F. P. Bell, W. M. Grogan, and F. W. Quackenbush. 1 978.  
Arylsulfo nate esters of fatty alcohols IV. Effects on cholesterol catabolism. Lipids 
1 3 : 627-635 .  
Klemsz, M .  J., S. R.  Mckercher, A.  Celada, C. van Beveren, and R.  A.  Maki. 1 990. 
The macrophage and B cell-specific transcription factor PU. l  is related to its oncogene. 
Ce11 6 1 : 1 1 3- 1 24.  
Kraemer, F. B.,  S. Patel, M. S.  Saedi, and C. Sztalyrd. 1 993.  Detection of hormone­
sensit ive lipase in various tissues: I. Expression of an HSUbacterial fusion protein and 
generat ion of anti-HSL antibodies. J .  Lipid Res. 34:663-67 1 .  
Langin, D., H. Laurell, L. S. Holst, P. Belfrage, and C. Holm. 1 993 .  Gene 
organization and primary structure of human hormone-sensitive lipase: possible 
significance of a sequence homology w ith a lipase of Moraxella T A 1 44, an antarctic 
bacterium. Proc. Nat!. Acad. Sci. USA 90:4897-490 1 .  
Lidberg, U.,  J. Nilsson, K. Stromberg, G. Stenman, P. Sahlin, S. Enerback, and G. 
Bjursell. 1 992. Genomic organization, sequence analysis and chromosomal localization 
1 02 
of the human carboxyl ester lipase (CEL) gene and a CEL-I ike (CELL) gene. Genomics 
1 3 :630-640. 
Lidmer, A. S., M. Kannius, L. Lundberg, G. Bjursell, and J. Nilsson. 1 995 .  
Molecular c loning and characterization of the mouse carboxyl ester lipase gene and 
evidence for expression in the lactating mammary gland. Genornics 29: 1 1 5- 1 22 .  
Liscum, L. ,  and K. W. Underwood. 1 995.  Intracellular cholesterol transport and 
compartmentation. J. B ioi .  Chern. 270: 1 5443- 1 5446. 
Lombardo, D., 0. Guy, and C. Figarella. 1 978.  Purification and characterization of a 
carboxyl ester hydrolase from human pancreatic juice. B iochim. B iophys. Acta 527 : 1 42-
1 49 .  
Lombardo, D. ,  G. Montalto, S. Roudani, E. Mas, V.  Sbarra, and N.  Abouakil. 1 993.  
Is serum bi le salt-dependent l ipase concentration in serum of any help in pancreatic 
cancer diagnosis? Pancreas 8 :58 1 -588.  
Lopez, J. M., M. K. Bennett, H. B. Sanchez, J. M. Rosenfeld, and T. F. Osborne. 
1 996. Sterol regulation of acetyl coenzyme A carboxylase: a mechanism for coordinate 
control of cellular lipid. Proc. Natl. Acad. Sci. 93: I 049- 1 053.  
Lundberg, B. B., G. H. Rothblat, J. M. Glick, and M. C. Phillips. 1 990. Effect of 
substrate physical state on the activity of acid cholesteryl ester hydrolase. B iochim. 
B iophys. Acta 1 042 :30 1 -309. 
Luscher, B., E. A. Kuenzel, E. G. Krebs, and R. N. Eisenman. 1 989. Myc 
oncoproteins are phosphorylated by casein kinase II. EMBO J. 8 : 1 1 1 1 - 1 1 1 9 .  
Martinez, M .  J.  and K. M. Botham. 1990. Cholesteryl ester hydrolase: three activit ies 
in the lactating mammary gland. B iochem. Soc. Trans. 1 8 : 6 1 9-620. 
M ickel, F. S., F. Weidenbach, B. Swarovsky, K. S. LaForge, and G. A. Scheele. 1 989. 
Structure of the canine pancreatic lipase gene. 
Natarajan, R., S. Ghosh, and W. M. Grogan. 1 996. Age-related changes in mRNA, 
protein and catalytic activity of hepatic neutral cholesterol ester hydrolase in male rats: 
evidence for transcriptional regulation. B iochim. Biophys. Acta 1 302: 1 53- 1 58 .  
Natarajan, R.,  S. Ghosh, and W. M. Grogan. 1 996a. Catalytic properties of the 
purified rat hepatic cytosolic cholesteryl ester hydrolase. B iochem. Biophys. Res. 
Commun. 225 :4 1 3-4 19 .  
1 03 
Natarajan, R., S. Ghosh, and W. M. Grogan. 1 997. Age-related changes in catalytic 
activity, enzyme mass, mRNA and subcel lular distribution of hepatic neutral cholesterol 
ester hydrolase in female rats. Lipids 32 :463-470. 
Nielsen, D. A., J. Chou, A. J. Maclmell, M. J. Casadaban, and D. F. Steiner. 1 983 .  
Expression of a preproinsu lin-beta-galactosidase gene fusion in mammalian cells. Proc. 
Nat!. Acad. Sci. 80:5 1 98-5202. 
Nilsson A. 1 976. Hydolysis of chyle cholesterol esters with cell free preparations of rat 
l iver. B iochim. B iophys. Acta 450. 379-389. 
Nilsson, J.,  L. Blackberg, P. Carlson, S. Enerback, 0. Hernell, and G. Bjursell. 1 990. 
CDNA cloning of human milk bile salt-stimulated l ipase and evidence for its identity to 
pancreatic carboxyl ic ester hydrolase. Eur. J. B iochem. 1 92:543-550. 
Nishimoto, M., 0. Gotoh, K. Okuda, and M. Noshiro. 1 99 1 .  Structural analysis of the 
gene encoding rat cholesterol ?a-hydroxylase, the key enzyme for bile acid synthesis. J. 
B ioi .  Chern. 266 :6467-647 1 .  
Osborne, T. F., G. Gil, J, L. Goldstein, and M. S. Brown. 1 988. Operator constitutive 
mutation of 3-hydroxy-3-methyl glutaryl coenzyme A reductase promoter abolishes 
protein binding to sterol regulatory element. J .  B ioi. Chern. 263 :3380-3387. 
Payvar, F., D. DeFranco, G. L. Fireston, B. Edgar, 0. Wrange, S. Okret, J-A, 
Gustafsson, and K. R. Yamamoto. 1 983 .  Sequence-specific binding of glucocorticoid 
receptor to MTV DNA at sites within and upstream of the transcribed region. Cell 
35 :38 1 -392. 
Pearson, B .  E.,  H. Nasheuer, and T. S. Wang. 1 99 1 .  Human DNA polymerase a gene: 
sequences control l ing expression in cycling and serum stimulated cells. Mol. Cell. B ioi .  
I I  : 208 1 -2095. 
Pittman, R., J, Khoo, and D. Steinberg. 1 975.  Cholesterol esterase in rat adipose tissue 
and its activation by cycl ic adenosine 3' 5 ' - monophosphate dependent protein kinase. J. 
B ioi .  Chern. 250:4505-45 1 1 . 
Pittman, R. C. and D. Steinberg. 1 977. Activatable cholesterol esterase and 
triacylglycerol l ipase activities of rat adrenal and their relationship. B iochim. B iophys. 
Acta 487:43 1 -444. 
Rice, D. A., M. S. Kronenberg, A. R. Mouw, B. P. Schimmer, and K. L. Parker. 
1 990. Multiple regulatory elements determine adrenocotrical expression of sterol 2 1 -
hydoxylase. J. B ioi. Chern. 265 : 8052-8059. 
1 04 
Rudd, E. A., N. K. Mizuno, and H. L. Brockman. 1 987. Isolation of two fonns of 
carboxyl  ester lipase (cholesterol esterase) from porcine pancreas. B iochim. B iophys. 
Acta 9 1 8 : 1 06- 1 1 4. 
Rudd, E. A., and H. L. Brockman. 1 984. in Lipases (Borgstrom, B. ,  and H. L. 
Brockman, eds) pp 1 85-204, Elsevier, Amsterdam. 
Small, C. A., J. A. Goodacre, and S. j. Yeaman. 1 989. Hormone-sensitive lipase is 
responsible for the neutral cholesterol ester hydrolase activity in macrophages. FEBS 
Lett. 247 :205-208 . 
Shupnik, M. A., W. W. Chin, D. S. Ross, J, F. Habener, and E. C. Ridgway. 1 985. 
Transcriptional regulation of the thyrotropin subunit genes by thyroid hormone. J.  B ioi. 
Chern. 260:2900-2903 . 
Simonet, W. S., and G. S. Ness. 1 989. Post-transcriptional regulation of 3-hydroxy-3-
methyl g lutaryl coenzyme A reductase mRNA in rat liver: Glucocorticoids block the 
stabilization caused by thyroid hormones. J. Bioi. Chern. 264:569-573. 
Smith, P. K., R. I. Krohn, G. I. Hermanson, A. K. Mallia, and F. M. Gartner. 1 985 .  
Measurement of protein using bicinchoninic acid. Anal. B iochem. 1 50:76-85.  
Smith, J, R.,  T.  F. Osborne, M. S. Brown, J, L.  Goldstein, and G. Gil. 1 988.  Multiple 
sterol regulatory elements in promoter for hamster 3-hydroxy-3-methyl glutaryl 
coenzyme A synthase. J.  B ioi. Chern. 263 : 1 8480- 1 8487. 
Spady, D. K. and J, A. Cuthbert. 1 992. Regulation of heoatic sterol mechanism in the 
rat. Parallel regulation of activity and mRNA for ?a-hydroxylase but not for 3-hydroxy-
3-methyl glutaryl coenzyme A reductase and low density lipoprotein receptor. J.  Bioi .  
Chern. 267 : 5584-559 1 .  
Strahle, U.,  W. Schmid, and G. Schutz. 1 987. A DNA sequence of 1 5  base pairs is 
sufficient to mediate both glucocorticoid and progesterone induction of gene expression. 
Proc. Nat!. Acad. Sci USA 84:787 1 -7875. 
Sudhof, T. C., D. R. van der Westhuyzen, J, L. Goldstein, M. S. Brown, and D. W. 
Russell. 1 987.  Three direct repeats and a TAT A-like sequence are required for regulated 
expression of the human low density l ipoprotein receptor gene. J. B ioi .  Chern. 
262: 1 0773- 1 0779. 
Swick, A. G., and M. B. Lane. 1 992. Identification of a trancription repressor down­
regulated during preadipocyte differentiation. Proc. Nat!. Acad. Sci USA 89:7895-7899. 
1 05 
Tamura, T. A., Y. Makino, K. Mikoshiba, and M, Muramatsu. 1 992. Demonstration 
of a testis-specific trans-acting factor Tet- 1 in vitro that binds to the promoter of the 
mouse protamine I gene. J. B ioi .  Chern. 267 :4327-4332. 
Tontonoz, P., J, B.  Kim, R. A. Graves, and B. M. Spiegelman. 1 993.  ADD ! :  a novel 
helix-loop-helix transcription factor associated with adipocyte determination and 
differentiation. Mol.  Cell .  B ioi .  1 3 :4753-4759. 
Trzeciak, W. H., and G. S. Boyd. 1 974. Activation of cholesteryl esterase in bovine 
adrenal cortex. Eur. J. B iochem. 46:20 1 -207. 
Wang C. S.  1 988 .  Purification of carboxyl ester lipase from human pancreas and the 
amino acid sequence of the N-terminal region. B iochem. B iophys. Res. Commun.  
1 55 :950-955. 
Wang, C. S. and J, A. Hartsock. 1 993.  B ile salt-activated lipase: a multiple function 
l ipolyt ic enzyme. B iochim. B iophys. Acta 1 1 66: 1 - 1 9. 
Wang, X., R. Sato, M. S. Brown, X. Hua, and J, L. Goldstein. 1 994. SREBP- 1 ,  a 
membrane bound transcription factor released by sterol regulated proteolysis. Cell 77:53-
62.  
Yamamoto K. R. 1 985.  Steroid receptor regulated transcription of specific genes and 
gene networks. Annu. Rev. Genet. 1 9 :209-252. 
Yokoyama, C., X. Wang, M. R. Briggs, A. Admon, J, Wu, X. Hua, J, L. Goldstein 
and M. S. Brown. 1 993.  SREBP- 1 a basic helix- loop-helix leucine zipper protein that 
controls transcription of the low density l ipoprotein receptor gene. Cell 75 :  1 87- 1 97 .  
Young, S., P .  J .  Parker, A .  Ullrich, and S .  Stabel. 1 987. Down-regulation o f  protein 
k inase C is due to an increased rate of degradation. B iochem. J.  244:775-779. 
VITA 
1 06 
